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Rebecca Elizabeth Foust 
 
THE EXPERIENCE OF POST-CRANIOTOMY PAIN AMONG PERSONS WITH BRAIN 
TUMORS 
 
Post-craniotomy brain tumor patients often experience pain in the post-surgical 
period which can negatively affect recovery and surgical outcomes. Research with this 
population has focused on pharmacological treatments of post-craniotomy pain and 
measurement of pain intensity. Little is known about how these patients experience the 
quality of their pain and how this pain is managed. The purpose of this dissertation was 
to provide an in-depth description of the experience of post-craniotomy pain during the 
post-surgical period. The information gained about how post-craniotomy patients 
experience pain and pain management will contribute the development of effective, 
tailored interventions to enhance patient satisfaction and outcomes. This dissertation 
project was composed of two components. The first component was an integrative 
review of literature examining the evidence of pain and associated symptoms in adult 
(aged 21 and older), post-craniotomy brain tumor patients. The review examined studies 
from the past fourteen years that focused on the incidence and treatment of post-
craniotomy pain. It revealed that the majority of post-craniotomy patients experience 
moderate to severe pain after surgery. This pain is associated with nausea, vomiting, 
changes in blood pressure, and increased length of hospital stay. The second 
component was a qualitative descriptive study of a sample of 28 adult (aged 21 and 
older) post-craniotomy patients hospitalized on an inpatient neurosurgical stepdown unit 
at a Midwestern urban teaching hospital. During semi-structured interviews, participants 
described their experiences of post-craniotomy pain and of their experiences of post-
craniotomy pain management. Data generated from the qualitative descriptive study 
were analyzed and resulted in two qualitatively derived products. The first was a 
description of participants’ experiences of the quality of their post-craniotomy pain during 
 vii 
 
the post-surgical period. The six types of pain quality described were pain as pressure, 
pain as tender or sore, pain as stabbing, pain as throbbing, pain as jarring, and pain as 
itching. The second was a description of how post-craniotomy patients experience the 
management of their pain during the post-surgical period. The four groups of types of 
pain management experiences described were pain-as-non-salient, routine pain 
management; pain-as-non-salient, complex pain management; pain-as-salient, routine 
pain management; and pain-as-salient, complex pain management.  
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CHAPTER ONE 
 Chapter 1 introduces the dissertation project on pain in the post-craniotomy brain 
tumor patient. The dissertation includes an integrative review of the literature and a 
qualitative descriptive study. This chapter provides a discussion of the significance of the 
topic, describes the purpose and specific aims of the dissertation, discusses the 
theoretical basis for this work, defines concepts that will be used throughout, and 
outlines study methods and limitations. In addition, this chapter will introduce Chapters 2 
through 5. 
Significance and Background 
Brain Tumors  
Brain tumors are masses of cells whose replication is unregulated, resulting in 
abnormal growths within the brain.1 Approximately 85-90% of central nervous system 
tumors are brain tumors.2 The incidence of primary malignant brain tumors worldwide is 
3.4 per 100,000 persons.3 In the United States, the incidence of malignant and benign 
primary brain tumors is 22.64 per 100,000 persons with over 375,000 new cases of 
primary and metastatic brain tumor diagnosed per year.3 In 2017, it was estimated that 
over 80,000 new cases of primary brain tumor were diagnosed of which over 23,000 
were malignant.4,5 Approximately 700,000 people in the United States are currently living 
with brain tumors.6,7 Survival rates vary significantly by tumor type,4,6 with increasing age 
associated with lower survival rates.4 Average five-year survival rates range from as low 
as 5% for a 55-64 year-old patient diagnosed with a glioblastoma to as high as 92% for a 
20-44 year-old patient diagnosed with an ependyoma.4 Average five-year survival rates 
for all types of malignant brain tumor are slightly over 30%.8 
Tumors originating in the brain are classified as primary brain tumors, whereas 
those originating elsewhere in the body are classified as metastatic brain tumors.9 As 
with other types of tumors, brain tumors can be benign or malignant, although unlike 
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other types of tumors, brain tumors rarely spread to other areas of the body and are 
more likely to spread within the brain tissue itself.1 Based on the appearance of the cells 
underneath a microscope, brain tumor severity is classified as Grade I-IV according to 
World Health Organization (WHO) guidelines. Grade I tumors are the least invasive and 
require less aggressive treatment, and Grade IV tumors are the fastest-growing and 
most invasive and require more aggressive treatment.9,10 Brain tumors are also classified 
based on the location of origin.9,11 Although brain tumors commonly arise from glial cells, 
which are cells that support the brain’s nerve cells, tumors can also originate in the 
meninges and in other areas of the brain such as the hypothalamus.1 The most common 
types of brain tumors are gliomas, with astrocytomas, oligodendrogliomas, and 
ependyomas being less common.9,11 Other types of brain tumors include meningiomas, 
medullablastomas, gangliomas, and schwannomas.9,11  
The symptoms associated with brain tumors vary with the location of the tumor.1,7 
For example, tumors located in the cerebellum can cause poor coordination and 
imprecise movement of limbs, tumors in the brain stem can affect breathing and 
heartbeat, and tumors in cranial nerves can cause problems with vision, swallowing, or 
hearing.1 Headache, seizures, cognitive changes, and mood swings are symptoms 
frequently associated with brain tumors.7  
Craniotomies 
Craniotomies are the removal of a section of bone in order to access the brain.12 
They are the most common treatment for brain tumor, regardless of tumor type.12 The 
section of skull bone is removed using specialized tools and replaced after surgery.12  
Craniotomies can be performed with computerized guidance and concurrent imaging, 
which can enable better identification of tumor versus non-tumor tissue.12 Craniotomies 
allow the surgeon to establish an accurate diagnosis and to remove as much of the 
tumor as possible13 and may be followed with chemotherapy and/or radiation.14 
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Craniotomies are classified according to where on the head they are 
performed.12 For example, bifrontal craniotomies expose the forehead through an 
incision behind the hairline.12 These types of craniotomies allow the surgeon to remove 
more bone and manipulate less brain tissue and are frequently used for tumors that are 
inoperable using other techniques.12 Retro-sigmoid craniotomies allow for visualization 
of the skull base through an incision behind the ear allowing access to the cerebellum 
and brainstem and are frequently used for removal of meningiomas and vestibular 
schwannomas.12  
Post-craniotomy Pain 
Brain tumor patients who have had craniotomies are assumed to experience little 
post-surgical pain because there are few pain receptors in brain tissue.15 Yet upwards of 
60% of post-craniotomy patients experience moderate to severe pain after surgery.15-17  
Post-craniotomy pain can result from surgical incisions, muscle retraction and reflection, 
and irritation of the meninges.15 Greater intensity of post-craniotomy pain is related to 
greater tissue damage during surgery.15 Post-craniotomy pain has been described as 
similar to that of a tension headache and can be unremitting.15,18 Post-craniotomy pain 
varies according to the surgical site, with frontal craniotomies being associated with less 
pain than those performed at the skull base.15  
Post-craniotomy pain in alert and oriented patients is primarily assessed using 
numerical pain ratings, such as visual analogue scales, numerical rating scales or visual 
numeric scales.15 A recent review of 26 studies of treatment for post-craniotomy pain 
revealed that all of the studies used one-dimensional numerical ratings to assess pain 
intensity and did not measure other aspects of pain such as timing, distress, affect, and 
quality.16 If post-craniotomy patients cannot describe their pain after surgery, provider 
observation of behavior may be necessary to assess pain.15   
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Treatments for Post-Craniotomy Pain 
 Treatment for post-craniotomy pain includes a variety of pharmacologic 
interventions, although most have limitations. Local anesthetics, such as scalp blocks, 
decrease post-craniotomy pain but wear off quickly.15,18 Parenteral and/or enteral opioids 
are commonly used to control post-craniotomy pain but have a number of adverse 
effects including sedation, respiratory depression, and neurological changes.17-21 Other 
pharmacologic interventions to control post-craniotomy pain include the use of nonopioid 
analgesics such as paracetamol and COX-2 inhibitors and antiepileptics such as 
gabapentin.15,18 The American Pain Society considers nonpharmacological interventions 
such as acupuncture, massage, and cold or heat therapy to be safe for pain 
management, although few studies have examined the efficacy of these interventions in 
the post-craniotomy pain population.22 
Outcomes of Untreated Post-Craniotomy Pain 
Uncontrolled post-craniotomy pain is associated with increased anxiety and 
depression,23 increased intracranial pressure and blood pressure,15,17,18,24 nausea, 
vomiting, and restlessness.17,24 The development of such side effects contributes to 
compromised neurological examination15,17 and prolonged hospital stay.25,26 Post-
craniotomy pain is also associated with decreased patient satisfaction,27,28 increased 
healthcare costs,18,26 increased disability, decreased quality of life, and increased 
mortality.17 Poorly managed post-craniotomy pain can result in the development of 
persistent pain due to changes in neurological sensitivity precipitated by nerve injury.29,30 
Need for Further Research    
Pain is a complex symptom is that comprised of multiple dimensions including 
intensity, duration, affect, quality, and location.31,32,33 Most research on post-craniotomy 
pain, however, has focused on the efficacy of pharmacological treatments.16 Therefore, 
despite the prevalence and negative outcomes associated with post-craniotomy pain,29 
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little is known about the experience of post-craniotomy pain from the perspectives of 
patients.34 To improve pain care in this population, information about how patients 
experience the quality of their pain and how they view their pain management 
experiences is needed.  
Purpose and Aims 
The purpose of this project was to provide an in-depth description of the 
experience of post-craniotomy pain during the post-surgical period. The specific aims 
were as follows: 
Aim 1: To conduct an integrative literature review to examine the evidence of pain and 
associated symptoms in adult, post-craniotomy brain tumor patients hospitalized on 
intensive care units (Chapter One). 
Aim 2: To describe how persons who have undergone a craniotomy for the excision and 
removal of a brain tumor describe the quality of their pain during the post-surgical period 
(Chapter Two). 
Aim 3: To describe how persons who have undergone a craniotomy for the excision and 
removal of a brain tumor experience pain management during the post-surgical period 
(Chapter 3). 
Theoretical Perspective 
 The Theory of Unpleasant Symptoms (TOUS) was used as a theoretical basis for 
this dissertation project. While some theories, such as the University of Minnesota’s 
Symptom Experience in Time (SET),35 the Symptoms Experience Model (SEM),36 and 
the Theory of Symptom Management (TSM), have addressed overall symptom 
experiences,37,38 and some theories, such as the Gate Control Theory39,40 and the 
Neuromatrix Theory, have addressed pain more specifically,41 the TOUS provides the 
foundation for this project because it considers symptom experiences, including pain, 
through a broad lens.  
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 While much of the research on post-craniotomy pain focuses on the intensity of 
the pain and pharmacological treatments, I was interested in the overall experience of 
post-craniotomy pain including its quality and how it is managed in the post-surgical 
period. Therefore the TOUS was chosen to underpin this dissertation because it 
addresses several aspects of the symptom experience42 and has been used to study 
symptoms in various populations,43-46 including patients with cancer.42 Because the 
TOUS addresses symptoms in a comprehensive way, it makes it an ideal foundation for 
a project seeking an in-depth description of the experience of post-craniotomy pain from 
the patient’s perspective. 
The TOUS was first purposed by Elizabeth Lenz in 1995.47 The theory posits that 
symptoms occur alone or in conjunction with other symptoms and when symptoms are 
experienced simultaneously, they have the potential to catalyze each other. If one 
symptom is alleviated, therefore, it is possible that other symptoms would be eased as 
well.42 This effect has been shown in studies in which the treatment of pain resulted in 
decreased depression and/or anxiety.48-51 The TOUS also asserts that symptoms can 
either be caused by a single event or can develop over time.42  
According to the TOUS, three reciprocal components affect the symptom 
experience: 1) the symptom itself; 2) the influencing factors that either cause or affect 
the nature of the symptom; and 3) the consequences of the symptom.42 Influencing 
factors can be physiological, psychological, or situational.42 Physiological factors can 
include the patient’s age, developmental stage, and comorbidities associated with the 
illness.42 Psychological factors can include a persons’ emotional state, perceived level of 
self-efficacy, felt uncertainty associated with the illness, and the meaning ascribed to the 
illness.42 Situational factors can include persons’ social support system, occupation, and 
family or work demands.42 The influencing factors can interact with each other and with 
other symptoms to affect the experience of the symptom.42  The consequences of 
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symptoms are the effects the symptom has on functional and/or cognitive performance.42  
Functional performance is the ability to perform physical and mental tasks associated 
with the individual’s role in society, and cognitive performance is the ability to reason, 
concentrate, and problem solve.42  Thought patterns in particular are believed to 
influence the symptom experience.42 The relationships among  the symptoms, 
influencing factors, and consequences are considered to be reciprocal rather than 
linear.42 
The TOUS describes four different dimensions of symptoms: 1) intensity, (i.e., 
severity), 2) timing, (i.e., duration or frequency), 3) distress (i.e., perceived bother), and 
4) quality (i.e., how the symptom feels).42  The four dimensions interact with each other 
to produce the overall experience of the symptom.42  While these dimensions are all 
measurable, the dimension of quality can be difficult to assess and is often dependent 
on the patient’s culture and language.42 This dissertation focuses on the symptom of 
pain itself; the quality of pain, as described in this theory; and on the pain management 
experience, which can be an importing influencing factor. 
Concepts and Definitions 
The following table displays the definitions of the major concepts that will be used 
throughout this dissertation project. The definitions are divided according to the concepts 
related to my substantive focus (post-craniotomy pain) and the methodological 
approaches used to answer the specific aims.  
Substantive Concepts 
Concept Definition 
Pain A subjective experience comprised of 
sensory and emotional elements, 
including mental annoyance, suffering, 
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and/or distress.33,52-54  The characteristics 
of pain include intensity, affect, quality, 
and location.32,55  Pain is influenced by 
physiological, psychological, cultural and 
social factors.28,29 
Pain intensity The severity of pain typically measured 
with a numerical rating given by the 
patients indicating their present pain 
level.56 
Pain affect Impact of the pain on mood and 
enjoyment of life.57 
Pain quality How the pain feels, as described by the 
patient. For example, a patient may 
describe pain as burning, tingling, 
throbbing, dull, achy, etc.56 
Pain duration How long the pain has been experienced. 
Pain can be acute or persistent and can 
be consistent or intermittent.56 
Pain location Where the pain is located, which is of 
importance because many patients have 
pain at multiple sites.56 
Pain management Design of a comprehensive, 
multidisciplinary treatment plan to address 
pain.58 Includes evaluating and 
diagnosing the pain, prescribing 
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medications and/or performing 
procedures such as blocks and injections 
to improve pain, and coordination of 
additional treatments such as physical 
therapy, psychological therapy, or 
rehabilitation.58  
Numerical rating scale (NRS) A one-dimensional pain scale that asks 
the patient to rate the intensity of his or 
her pain from 0 to 10 or 0 to 100.59  
Higher numbers represent higher self-
reported levels of pain.59  The NRS 
correlates positively and significantly with 
other measures of pain intensity.59 
Visual analogue scale (VAS) A one-dimensional pain scale consisting 
of a line with endpoints labeled “no pain” 
and “worst pain.”59 Patients are asked to 
rate the intensity of their pain along the 
line.59  The VAS correlates with other 
measures of pain intensity and with pain 
behaviors.59 
Visual numeric scale (VNS) A one-dimensional pain scale consisting 
of a numeric scale with visual cues 
including bars of different heights and/or 
shades.60  Patients are asked to rate the 
intensity of their pain along the scale.60 
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The VNS correlates strongly with the 
VAS.60 
Cancer A group of related diseases where the 
body’s cells divide without stopping and 
may spread into other surrounding 
tissues.61  Cancer can begin anywhere in 
the body.61  Cancer may form solid 
tumors, although cancers of the blood do 
not.61 
Brain tumor Masses of cells whose reproduction is 
unregulated, resulting in abnormal 
growths in the brain.62 
Craniotomy Removal of part of the skull, exposing the 
brain. The removed portion of skull is 
replaced after the brain surgery is 
completed.12 
Supratentorial The front of the brain, consisting of the 
cerebrum.63 This region of the brain 
controls movement, vision, touch, 
hearing, judgment, reasoning, problem 
solving, memory, and emotions.63 
Infratentorial The back of the brain, consisting of the 
cerebellum.63 This region of the brain 
coordinates muscle movements, balance, 
and equilibrium.63 
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Post-surgical period The period immediately after surgery and 
typically extending throughout the hospital 
stay. 
Methodological Concepts 
Concept Definition 
Integrative review A review method that synthesizes 
literature, allowing for a comprehensive 
understanding of a phenomenon or 
healthcare problem.64  Integrative reviews 
allow for inclusion of different 
methodologies such as experimental and 
non-experimental designs.64 
Qualitative Description (QD) A research method that allows the 
researcher to describe the experiences of 
persons who share common health 
challenges.65  QD uses semi-structured 
interviews to generate data and describes 
the data in straight-forward terms using 
low-inference analytic strategies to 
generate surface descriptions of 
experiences.65  QD is frequently used to 
answer pragmatic questions.65 
Content analysis A systematic way of analyzing and coding 
written texts, allowing for quantification of 
qualitative data.66 
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Methods 
 The following section describes the methods used to meet the three specific 
aims. I conducted an integrative literature review for Aim 167 and a qualitative descriptive 
study for Aims 2 and 3.65 
Integrative Literature Review  
 An integrative literature review is a method used to summarize the findings of 
research studies that have been done on a given topic and that address the same or 
similar hypotheses.67 In this project, the integrative review strategies described by 
Cooper67 were used. Cooper outlines seven stages of an integrative review. The stages 
are 1) formulating the problem; 2) searching the literature; 3) gathering information from 
the studies; 4) evaluating the quality of the studies; 5) analyzing and integrating the 
outcomes of the studies; 6) interpreting the evidence; and 7) presenting the results.67    
 In the first stage, formulating the problem, the reviewer clearly identifies the 
hypotheses to be examined and conceptually and operationally defines the relevant 
variables.67 The reviewer decides if the purpose of the review is to describe the variables 
or to examine the relationships among them.67 In the second stage, searching the 
literature,67 the reviewer selects the target population to allow generalization to that 
population.67 The reviewer searches relevant data bases and complementary literature 
using pre-determined search terms to select the literature to be included in the review.67  
In the third stage, gathering information from the studies,67 the reviewer extracts relevant 
information according to pre-determined procedures.67 In the fourth stage, evaluating the 
quality of the studies, 67 the reviewer evaluates the relevancy of data and data are 
discarded if unrelated to the problem.67 The researcher also evaluates the quality or 
credibility of the studies according to pre-determined criteria and determines if study 
limitations warrant exclusion of the data.68 In the fifth stage, analyzing and interpreting 
the outcomes of the studies,67 the reviewer summarizes and integrates the data using 
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methods appropriate to the level of the data and identifies patterns.67 In the sixth stage, 
interpreting the evidence,67 the researcher determines what conclusions can be drawn 
based on the patterns of data.67 These conclusions may address whether the data 
supports or refutes the hypotheses in question and or the degree to which the results 
can be generalized to other situations.67 In the seventh stage, presenting the results,67 
the reviewer disseminates the findings of the review.67 How these procedures were 
implemented to address Specific Aim 1 is described in Chapter 2. 
Qualitative Descriptive Method 
 Qualitative Description (QD), as described by Sandelowski,65 is a method used to 
comprehensively describe events related to a phenomenon of interest in everyday 
terms.65 QD is often used in health sciences because it allows description of the 
experiences of persons who share common health challenges.65 QD is considered 
naturalistic inquiry as it focuses on the description of phenomena as they occur naturally 
in participants’ everyday lives. Researchers aim to create surface descriptions of 
participant experiences in straight-forward terms rather than producing highly complex, 
theoretical or conceptual renderings.65   
 Purposeful sampling, which is selection of individuals who are knowledgeable 
about a given experience, is often used in QD studies.69 Researchers use semi-
structured interviews to allow individuals to describe the “who, what, and where” of the 
phenomena in their own words65 with the goal of obtaining as many varied, information-
rich pieces of data possible.65 Data collection can also include focus groups and 
observation of events or artifacts.65   
 When analyzing data using this method, researchers stay close to the 
participants’ descriptions by using low-inference strategies such as coding and 
categorizing narrative text. Data are organized and presented in a way that best fits the 
data.65 Data may be arranged in chronological order related to the trajectory of the 
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phenomenon or in the order of frequency with which participants discuss certain topics 
or concerns65  The low-inference strategies increase the likelihood of researchers’ 
consensus on how data are represented.65 QD yields a comprehensive summary of the 
main characteristics of participants’ experiences that can be used to answer pragmatic 
questions.65  The implementation of QD methods to answer Specific Aims 2 and 3 are 
described in Chapters 3 and 4. 
 Credibility. Reliability and validity in the traditional sense often do not apply in QD 
studies. However, the credibility of QD studies is enhanced by procedures aimed at 
increasing the descriptive and interpretive validity and transferability of the findings.  
 Descriptive validity, as described by Sandelowski,65 is the accurate and objective 
reporting of events.65 In interview studies, descriptive validity depends on participants’ 
narratives being collected, recorded, transcribed, and represented accurately. In this 
study, interview guides were developed to encourage participants to describe all aspects 
of their pain experiences with as much detail as they were able. The interviews were 
audiotaped and transcribed verbatim by a professional transcriptionist. The primary 
researcher then compared each transcript with the audio recording to ensure accuracy.  
 Interpretive validity, as described by Sandelowski,65 reflects how well the 
researcher captures the meaning of events described by participants. Many analytic 
decisions made in this study were low inference, as is consistent with the QD methods, 
and thus offered little threat to interpretive validity. However, when interpretive decisions 
were made, such as how to group codes into categories and what to label the 
categories, several procedures were used to enhance the interpretive validity of the 
findings. First, an audit trail was maintained to provide a written record of all analytic 
decisions. This ensured that these decisions were made systematically and were well-
grounded in the data. Second, all analytic decisions that involved a higher degree of 
interpretation were made by discussion and consensus among the primary investigator 
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and her dissertation advisors and were always informed by a re-examination of the 
original transcripts. Third, emerging categories were presented to subsequent 
participants who were asked about the relevance of these categories to their own 
experiences. Their responses were used to refine or modify the categories. 
Transferability, according to Charmaz, is the process of showing that results of 
qualitative studies, while not generalizable in the traditional sense, can be applied in 
other contexts.70,71 Transferability is enhanced when researchers provide a detailed 
description of the setting in which the data were collected and the participants who 
comprised the sample. This information allows consumers of the research to determine if 
the results apply to their setting and population of interest. For this study, an in-depth 
description of the hospital system and the unit on which the study took place are 
provided as is a considerable amount of demographic and medical information related to 
the participants who were interviewed. Threats to validity and transferability due to study 
limitations are discussed in Chapters 3 and 4.  
Structure of the Dissertation  
 The remainder of this dissertation is structured as follows. Chapter Two is an 
integrative review of the literature related to post-craniotomy brain tumor pain (Aim 1). 
Sections of this chapter were integrated in a study published in the Journal of Advanced 
Nursing.16 Chapter Three presents the finding of a qualitative descriptive study that 
describes how persons who have undergone a craniotomy for the excision and removal 
of a brain tumor describe the quality of their pain during the post-surgical period (Aim 2). 
Chapter Four presents the finding of a qualitative descriptive study that describe how 
persons who have undergone a craniotomy for the excision and removal of a brain tumor 
describe their pain management experiences during the post-surgical period (Aim 3). 
Chapter Five summarizes and synthesizes the main findings of the integrative review 
and the qualitative descriptive studies, discusses clinical implications of the overall 
 16 
 
findings of the dissertation projects, and makes recommendations related to future post-
craniotomy pain research. 
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CHAPTER TWO 
 This chapter present the results of an integrative review which examined the 
evidence of pain and associated symptoms among adult (> age 21), post-craniotomy, 
brain tumor patients who had been hospitalized on intensive care units.  
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Introduction 
Background 
Brain tumor is the seventeenth-most diagnosed cancer worldwide, with 256,000 
new cases of brain tumor diagnosed in 2012.72 Men suffer from brain cancer slightly 
more frequently than women72-75 and incidence rates are higher in developed countries 
than in lesser developed countries.72-74 Scientific advances have resulted in 
improvements in the diagnosis and treatment of brain tumors.72 In fact, one- and five-
year survival rates have increased from 7.3% in 1970 to over 18% in 2011.75-78  
Approximately 90% of patients with brain tumors undergo craniotomies for 
excision and removal of the tumor to increase survival.79 Surgical procedures are 
generally understood to be painful80 but less is understood about post-craniotomy pain. 
Healthcare providers commonly believe that craniotomies are less painful than other 
types of surgery due to lack of innervation in the brain81,82 and are thus less apt to treat 
pain. In addition, post-craniotomy pain is often untreated or undertreated due to 
concerns that it may mask neurological changes in these patients.83-85 Pain is often 
associated with other symptoms including anxiety and depression80,86 and nausea and/or 
vomiting.87 Understanding post-craniotomy pain in brain tumor patients is important 
because post-operative pain is a common cause of delayed mobilization,88 lengthened 
hospital stay,88-90 disability and decreased quality of life.91,92 In addition, research has 
shown that under-treated, generalized post-operative pain is a predictor of the 
development of persistent pain.93-97 To date, post-craniotomy pain and the symptoms 
associated with it is poorly understood. Researchers have called for additional studies to 
understand influencing factors and associated symptoms of post-craniotomy pain and to 
determine how to best treat it to prevent negative health outcomes.83,86,98-100 
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Definitions and Theory 
 The International Society for the Study of Pain describes pain as a subjective 
sensory and emotional experience.80,94,101 Pain is a complex symptom comprised of at 
least four dimensions (intensity, affect, quality, and location).102,103 Physical, 
psychological, social, and cultural factors influence the experience of pain.88,104  
 The Theory of Unpleasant Symptoms (TOUS), which suggests that symptoms 
such as pain are multidimensional and interactive, is commonly used to support pain 
research because it is relevant to practice and can be used as a framework for making 
decisions related to patient care.105,106 The TOUS includes three main concepts: (1) 
physiological, measureable symptoms experienced by the patient; (2) influencing factors 
which alter the patient’s experience of the symptom; and (3) patient performance.106,107  
Influencing factors are physiological, psychological, and situational in nature and can 
catalyze each other affecting patient performance.106,107 Performance is the impact of the 
symptom on patient outcomes including functional performance (the ability to physically 
function) and cognitive performance (the ability to think).106,107 Researchers using the 
TOUS have termed groups of associated symptoms as “clusters.”75,107 This review will 
also use the term cluster to identify these groups of co-related symptoms.  
The Review 
Aim 
The aim of this study was to conduct an integrative review using the TOUS as a 
guiding framework to synthesize and examine what is known about the phenomenon of 
pain in adult (≥21 years of age), post-craniotomy, brain tumor patients. Specifically, this 
review sought to answer the following research questions: (1) What is the evidence for 
post-craniotomy, post-brain tumor pain in adult (≥21 years of age) patients hospitalized 
on intensive care units?; and (2) What is the evidence for a post-craniotomy symptom 
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cluster associated with pain in adult (≥21 years of age) patients hospitalized on intensive 
care units? 
Design 
Cooper’s108 integrative review method guided the review. This method of 
integrative review was chosen because it provides a systematic framework to synthesize 
the current literature regarding post-craniotomy pain in the brain tumor patient.109,110 
Cooper’s method includes seven stages: advance formulation of the problem, data 
collection, data extraction, evaluation, analysis, interpretation, and presentation of the 
results.110 The formulation of the problem, the first stage of the method, was informed by 
a preliminary literature search and the researchers’ clinical experience that suggested a 
greater understanding of acute post-craniotomy pain was warranted. The authors felt an 
integrative review was necessary to synthesize the current literature and further the state 
of the science.109,110 
Search Methods  
 Data collection, the second stage, consisted of a literature search. Studies were 
identified for inclusion by purposive searching of electronic databases including Medline, 
OVID, PubMed, and CINAHL. In addition, hand-searching of references and an 
examination of citations from identified published reviews were conducted. Two 
experienced reference librarians provided consultation on the search process. Search 
terms for all databases and searches included traumatic brain injury; pain, postoperative; 
brain injuries; postoperative pain; craniotomy; decompressive craniectomy; and 
trephining. Inclusion criteria were as follows: (1) data-based quantitative and qualitative 
articles focused on post-craniotomy pain in adult brain tumor patients aged 21 or older; 
(2) published between 1/1/2000 and 12/31/2014; (3) English-language; (4) neurosurgical 
inpatients; and (5) intensive care unit settings. Abstracts, editorials, dissertations, 
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theses, reviews, and articles concerning intraoperative pain control, end-of-life care, or 
institutional practices were excluded.  
Search Outcome 
 The search strategy generated 115 studies. The studies which were recorded in 
a Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) 
diagram. (See Figure 2.1.) A total of 109 potentially relevant studies remained after the 
initial screening of titles for duplicates, publication in English, and publication dates. The 
remaining abstracts were reviewed for type of study, population, study setting, and 
discussion of pain. After application of the inclusion and exclusion criteria, we eliminated 
83 additional articles from review, including five qualitative studies that either did not 
meet inclusion criteria because they did not focus on pain or the participants were not in-
patients. This resulted in a sample of 26 quantitative articles to be reviewed in full-text 
format. (See Table 2.1). Data from eligible studies were abstracted into tables listing 
general information, level of evidence, and concepts defined in the TOUS. 
Quality Appraisal 
In the third stage, two authors completed a quality appraisal on the 26 articles. 
Using a 3-point scale (yes, no, unclear) described by Gazarian, they rated the studies on 
nine criteria including aims, design, methods, sample, ethical considerations, results, 
limitations, implications, and sponsorship.111  The studies were also appraised for bias 
using the Cochrane Risk of Bias tool. Twenty-one of the studies used a randomized 
design. Of the five studies that did not use randomization, two were retrospective,112,113 
and three were prospective trials.114-116 The team determined that these five studies 
nonetheless met inclusion criteria and thus all 26 studies are included in the review. 
Data Abstraction 
The fourth stage includes data analysis and interpretation.108 In this stage, all of 
the included studies were read in full and relevant data were extracted and tabulated. 
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Table 2.1 displays the authors’ names; dates and countries of publication; purpose and 
design; sample, setting and intervention; medication tested; and pain prevalence, 
incidence, and intensity. (See Table 2.1). 
Data Synthesis 
 In the fifth and final stage, the tabulated data were synthesized to address the 
research questions.108 The authors grouped the data into categories suggested by the 
TOUS including incidence of pain, influencing factors, cluster, and patient performance. 
(See Table 2.2). Two of the authors (RG & DV) reviewed each study and verified the 
accuracy of data as presented and over several meetings compiled the results. 
Results 
Description of the Studies 
Of the 26 studies included, all were pharmacological pain management trials 
(pain medications) and most were randomized, controlled trials (RCTs) (n = 21). The 
studies included 1892 total patients and were originally designed to test local wound 
infiltration or medications to control pain (intravenous, intramuscular, oral medications, 
nerve blocks, general anesthesia) (See Table 2.1). The medications that were tested 
varied but mostly included bupivacaine, ropivacaine, tramadol, parecoxib, paracetamol, 
and morphine.  
The mean ages of the participants in the studies ranged from 45 to 55, and 
approximately equal numbers of men and women were represented. The 
comprehensive search identified five qualitative studies; however, these did not meet 
inclusion criteria (focus not on pain or participants not in-patients) and were excluded 
from final analysis. The majority of trials took place outside of the United States at non-
profit, urban, academic medical institutions. Only one study reported racial 
characteristics of the sample that consisted mostly of Caucasians (52 versus 12 non-
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Caucasian).117 Reports included both supratentorial surgeries and infratentorial surgeries 
with mean lengths of surgery ranging between 200 and 300 minutes.  
Main Results 
 As previously discussed, we used the TOUS as the guiding framework for 
describing the experiences and cluster associated with post-craniotomy pain in brain 
tumor patients, which resulted in five categories: (1) evidence of pain; (2) manner of pain 
assessment; (3) influencing factors; (4) symptom cluster; and (5) patient performance 
(Tables 2.1 and 2.2).  
Evidence of Pain. Fifteen studies reported specific percentages of participants 
experiencing moderate-severe pain. These percentages were as high as 60-96% within 
the first two days after surgery, despite the use of analgesics. Participants in eight 
studies required additional pain medications, and in one study, inadequate analgesia in 
75% of participants necessitated the removal of one study arm.118 Within this arm, six of 
eight patients experienced inadequate analgesia and multiple infusions of additional pain 
medication were required to reduce pain intensity scores to below 30 (out of 100).118 An 
additional study reported the withdrawal of five participants for severe pain in the first 
post-operative hour.119   
Manner of Pain Assessment. Measures that were used to assess pain varied but 
most used one-dimensional assessments of intensity including visual analogue scales 
(VAS), numerical rating scales (NRS), visual rating scales (VRS), or visual numeric 
scales (VNS). Study authors did not measure other dimensions of pain such as timing, 
distress, affect, and quality. Twenty-one studies (81%) identified inadequate pain relief. 
Influencing factors. Table 2.2 displays the evidence of post-craniotomy pain, 
factors that may influence its development, an associated symptom cluster, and possible 
impact on patient performance. Many authors did not report all elements of the TOUS. 
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Eleven of the 26 studies (42%) discussed some physiological, psychological, or 
situational factors influencing post-craniotomy pain.  
Several studies examined physiological influencing factors such as included 
gender and age but findings were inconsistent. One study found that women tended to 
experience higher pain levels than men117 while another study found that men were 
more likely to ask for pain medication than women.120 The impact of age in the 
development of post-craniotomy pain also was not clear. One study found that older age 
was associated with less pain112 while another found increased pain levels in older 
patients.121 
Psychological influencing factors are the patient’s emotional reactions to the 
disease and can include mood and perceived level of self-sufficiency.106,107 No studies 
examined psychological factors that may influence the experience of post-craniotomy 
pain. 
Situational factors are found in the social and physical environment and can 
include surgical positioning, site of surgery, and use of anesthetics. Three studies 
reported less pain among patients with frontal craniotomies,112,113,116 and one study 
found that perioperative nerve blockade decreased the incidence of post-operative 
pain.117  General anesthetics used included sevoflurane and desflurane. The use of 
sevoflurane resulted in less pain in one study,122 while in another, patients receiving 
sevoflurane required additional medication to control their pain.123 
Clusters. Clusters in the TOUS are groups of co-related symptoms that interact, 
affecting the patient’s symptom experience.106,107 Although the researchers did not 
explicitly explore ‘symptom clusters,’ 21 (81%) studies discussed symptoms related to 
pain. Symptoms reported include headache nausea and vomiting, shivering, fatigue, 
dizziness, respiratory depression, constipation, neurologic changes, increased risk of 
intracranial bleeding, and agitation. The top three most common symptoms described 
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were nausea (15 studies; 58%), vomiting (16 studies; 62%), and changes in blood 
pressure including, but not limited to, the development of hypertension (9 studies, 35%). 
Patient performance. Patient performance is frequently assessed in terms of 
tangible functional outcomes, such as length of stay, readiness to be discharged, and 
perceived quality of life. Although performance related to post-craniotomy pain was not 
explicitly examined, almost half of the studies described potential results of post-
craniotomy pain (See Table 2.2). However, it was unclear if the impact on patient 
performance was a direct result of pain, the use of pain medication, or other factors. 
Other functional performance outcomes reported included increased cost of medication 
and increased hospital length-of-stay. In two different studies, poorly managed post-
craniotomy pain resulted in delayed discharge and altered quality of life.113,120 Four 
studies described changes in cognitive performance using the proxy measure of level of 
conscious assessed by the Glasgow Coma Scale (GCS).122-125 Two studies found 
changes in level of consciousness due to type and amount of analgesic used124,125 and 
one identified these changes as being the result of uncontrolled pain.122 
Discussion 
To our knowledge, this is the first integrative review of data-based studies 
examining: (1) evidence for post-craniotomy, post-brain tumor pain; and (2) the evidence 
for a post-craniotomy pain symptom cluster in brain tumor patients. Brain tumors affect 
many worldwide and pain has been identified as a public health priority. Accordingly, 
most research on post-craniotomy pain has been conducted in other countries. 
Research to date has focused solely on pharmacological intervention and fails to explore 
the multidimensional nature of pain through comprehensive assessment.126-129 Although 
pharmacological interventions exist, no one therapeutic medication has been identified 
as most efficacious.88,130-132 Our review found that despite the use of 18 different 
analgesics, moderate to severe pain still occurred among post-craniotomy brain tumor 
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patients and that many patients expressed inadequate pain management resulting in the 
need for more analgesics. This review provides strong evidence for the existence of 
post-craniotomy pain and the need for more research to develop evidence-based 
practice guidelines in this population. 
While researchers have begun to study patients’ subjective experiences after 
craniotomy, such as their fears, expectations, and satisfaction,133,134 these investigations 
have not yet addressed pain. Patients’ experiences of pain will necessarily be affected 
by amount of pain control and healthcare provider interaction, but the extent to which 
these influence post-craniotomy, post-brain tumor patient experience has not yet been 
made clear. Due to the complicated nature of post-craniotomy pain, further research is 
warranted to provide evidence-based care. 
A full understanding of the post-craniotomy pain experience from the patients’ 
perspectives would improve assessment of pain, planning of interventions, and 
evaluation of care.91,94,104 This review serves as a call to action to describe the context 
and unfolding of post-craniotomy brain tumor pain from the patient’s perspective and 
provides evidence to challenge the commonly held belief that post-craniotomy pain is not 
an important problem.81,82   
The intensity of post-craniotomy, post-brain tumor pain is well-documented. 
Measures such as VASs are capable of reflecting this intensity and change in pain over 
time.103  However, pain intensity is not necessarily correlated with level of patient 
distress and resulting patient performance.94,103,104,135,136 Consequences such as the 
development of dysfunction and disability reflect broader dimensions of pain that cannot 
be assessed by mere measures of intensity and distress.94,136 Current research fails to 
explore the pain experience beyond intensity and does not address the cluster of 
associated symptoms that may magnify pain and/or moderate treatment effects. 
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The limited and conflicting nature of the evidence concerning physiological 
factors that influence the development of post-craniotomy pain in the brain tumor patient 
suggests that additional, more comprehensive description is needed. Increased 
awareness of the experiences of post-craniotomy pain across age groups is needed.91 
Investigations of the experience of post-craniotomy, post-brain tumor pain by 
gender could lead to the development of targeted approaches for men and women. 
Similarly, while incidence of brain tumor is higher in Caucasians than in those of other 
racial backgrounds,79 few authors report racial characteristics of the study sample, 
preventing clear understanding of the manner in which post-craniotomy pain unfolds 
among different groups. 
  Psychological factors influencing the development of post-craniotomy, post-brain 
tumor pain are also thought to be important.80,91,104,106,135 None of the studies in the 
review, however, addressed these factor and thus it is not yet clear what role emotions, 
mood, and perceived level of self-sufficiency play in the unfolding and experience of 
post-craniotomy pain. 
Situational factors that affect the unfolding and experience of post-craniotomy 
pain also need further clarification. Longer surgical time influences length of intensive 
care unit stays in cardiac patients137 and length of surgery influences the severity of 
post-operative pain in ambulatory care surgical patients.89 In post-craniotomy patients, 
longer surgeries may increase post-surgical pain due to greater time spent in surgical 
positions, increased duration of muscle retraction, larger incisions, and the potential for 
more involved surgical procedures.90,113 Researchers should therefore investigate the 
impact of length of surgery on the development of post-craniotomy pain.  
More detailed comparisons could also be made if surgical diagnoses were 
consistently reported. For example, it is known that post-operative headache in occipital 
surgeries stems from resulting occipital neuralgia.113 Examining the effect of surgical 
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location on development of post-craniotomy headache could lead to better targeted 
interventions.  
The existence of a symptom cluster would call for comprehensive post-
craniotomy pain assessment.88,91,104 Little is known, however, about the cluster 
associated with post-craniotomy, post-brain tumor pain. Within the current science, 
effects of pharmaceutical interventions, post-craniotomy pain, other symptoms such as 
pain and anxiety, and patient performance are often confounded. Research that 
explicates the nature of symptom clusters in this population is needed.  
Literature shows that post-operative pain may affect performance by increasing 
length-of-stay, cost of hospitalization, and delaying discharge.88,94 Some research links 
post-craniotomy pain to increased length of stay and delayed readiness to be discharged 
in the traumatic head injury population.138,139 However, only a few studies have examined 
the impact of post-craniotomy pain on brain tumor patients’ functional and cognitive 
performance. 
Within the broader pain literature, untreated acute pain has been correlated with 
the development of long-term pain due to nervous system plasticity.94,104,113,135 In 
addition, researchers of general post-surgical pain have shown that inadequate post-
operative analgesia has led to the development of persistent pain.80,94,140 Batoz et al.141 
have shown that improved pain management in post-craniotomy patients during the 
acute post-operative period decreases the development of persistent pain at two 
months, but the relationship between post-operative pain management and persistent 
pain has not been well-studied in post-craniotomy brain tumor patients. Therefore, 
describing the connection between post-craniotomy pain and patient performance could 
lead to the development of interventions to prevent or minimize both post-craniotomy 
pain and its resulting effects.  
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Over forty years of research have repeatedly illustrated that pain is under-
assessed, under-recognized, and undertreated. The treatment of post-craniotomy pain is 
further complicated by a lack of understanding of the manner in which it unfolds over the 
course of the post-operative period and a reluctance to treat it aggressively for fear of 
masking neurological changes. The result is an unclear risk-benefit ratio associated with 
the treatment of post-craniotomy pain in brain tumor patients. Additional research would 
illuminate the relationship between post-craniotomy pain, influencing factors, associated 
clusters, and patient performance, leading to the development of timely interventions to 
control pain without increasing risk to patients. 
Limitations 
 This review was limited to examining studies that discussed particular influencing 
factors, associated clusters, and the effect of post-craniotomy, post-brain tumor pain on 
patient performance. It is possible that studies looking at post-craniotomy pain within a 
different context were missed. In addition, this review does not represent ongoing or 
unpublished studies, nor does it include published work that has not undergone the peer 
review process. 
Conclusion 
 Evidence suggests that post-craniotomy, post-brain tumor patients experience 
significant post-surgical pain but no guidelines have been established to treat this pain. 
Post-craniotomy pain may influence length of hospital stay, cost of medications, quality 
of life and development of persistent pain. However, little research has been conducted 
on the complex nature and experience of post-craniotomy, post-brain tumor pain. 
Mitigating or preventing post-craniotomy pain in the brain tumor population will likely 
result in improved patient outcomes. Patient-centered outcomes research should focus 
on attempting to understand post-craniotomy pain, which will pave the way for the 
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development of timely interventions and standardization of treatment for post-craniotomy 
pain to improve functional outcomes and quality of life. 
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Figure 2.1. PRISMA Diagram of Systematic Search 
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Table 2.1. Summary of Studies 
Author, Year, 
Country 
Design, Sample Size, Medication Existence of Pain and Pain Intensity, Rating Scale 
Used 
Bala et al. (2006) 
India 
Prospective, double-blind RCT; N = 40  
Medication: Scalp nerve block (bupivacaine) 
60% experienced moderate-severe pain in first 12h post-
op (control)  
25% experienced moderate-severe pain in first 12h post-
op (intervention) 
Rating Scale: NRS; scores 0-22.5 out of 100 
Batoz et al. (2009) 
France 
Prospective, single-blinded study; N = 52 
Medication: Incisional infiltration 
(ropivacaine); nalbuphine post-surgery 
VAS scores higher in control group 
Persistent pain significantly lower in intervention group at 
2 months (56% in control group vs. 8% in intervention 
group) 
Rating Scale: VAS; scores 0-35 out of 50 
Biswas and Bithal 
(2003) 
India 
Prospective, double-blind RCT; N =  50 
Medication: Incisional infiltration 
(bupivacaine) vs. fentanyl 
Additional medication needed in 60% of bupivacaine 
group and 57% of fentanyl group 
Rating Scale: VAS; scores 0-4 out of 10 
Ducic et al. (2012) 
United States 
Retrospective interview of patients; N = 7 
Medication: None tested 
86%  experienced pain greater than 80% on migraine 
index 
Rating Scale: VAS; scores 2-10 out of 10 
Ferber et al. (2000) 
Poland 
Multi-stage prospective study; N = 35 
Medication: Intravenous tramadol 
Pain relief in 50% of patients receiving one dose; in 88% 
of patients receiving 2 or 3 doses 
Rating Scale: VRS; scores 0-4 out of 5 
Girard et al. (2010) 
Canada 
Prospective, double-blind RCT; N = 30 Similar pain scores between nerve block and morphine 
groups 
Rating Scale: NRS; scores 2-7 out of 10 
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Medication: Cervical plexus nerve block 
(lidocaine and bupivacaine) vs. intravenous 
morphine bolus 
Grossman et al. (2007) 
Israel 
Open, prospective, double-blind non-
randomized, placebo- controlled study; N =  
40 
Medication: Incisional infiltration (lidocaine 
and bupivacaine); metamizol intra-operatively 
13 patients needed additional pain medication 
Rating Scale: NRS; scores 0-4 out of 10 
Irefin et al. (2003) 
United States 
Prospective study; N = 128 
Medication: None tested 
No significant difference in pain scores between groups 
Rating Scale: VAS; scores 0-5 out of 10 
Jellish et al. (2006) 
United States 
Prospective, double-blind RCT; N =  120 
Medication: PCA (morphine or morphine plus 
ondansetron) 
Up to 76% experienced post-op pain 
Administered analgesia was inadequate 
Rating Scale: VAS; scores 4.5-6.1 out of 10 
Jones et al. (2009) 
Australia 
Prospective, double-blind RCT; N =  50 
Medication: Intravenous parecoxib; morphine 
post-operatively 
89% of patients required additional pain medication 
(morphine)  
Pain scores significantly lower in parecoxib group only at 
6 hours 
Rating Scale:  VAS; scores 0-35 out of 100 
Law-Koune et al. 
(2005) 
France 
Prospective, double-blind RCT; N =  80 
Medication: Incisional infiltration (bupivacaine 
plus epinephrine) vs. ropivacaine  
Placebo group received more morphine than 
bupivacaine or ropivacaine groups (22.2 mg;12.7 mg; 
10.5 mg, respectively) 
Rating Scale: VAS; scores 0-7 out of 10 
Magni et al. (2005) 
Italy 
Prospective, randomized, open-label clinical 
trial; N = 120 
Medication: General anesthesia (sevoflurane-
fentanyl vs. propofol-remifentanil) 
10% of ropivacaine group and 6% of sevoflurane group 
experienced pain at 45 minutes 
Rating Scale: VAS; scores unclear out of 100 
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Magni et al. (2009) 
Italy 
Prospective, double-blind RCT; N = 120 
Medication: General anesthesia (sevoflurane 
vs. desflurane) 
22% of sevoflurane group and 17% of desflurane group 
required additional medication for pain 
Rating Scale: VAS; scores unclear out of 100 
Morad et al. (2009) 
United States 
Prospective RCT (unblinded); N = 64 
Medication: as needed intravenous fentanyl 
vs. PCA (fentanyl) 
Patients in PCA group had significantly lower pain 
scores than PRN group (2.53 versus 3.62, respectively) 
PCA group received significantly more fentanyl 
Rating Scale: NRS; scores 2-4.7 out of 10 
Nair and Rajshekhar 
(2011) 
India 
Prospective longitudinal study; N = 43 
Medication: Oral paracetamol 
5% had moderate pain in first post-op hour 
Significant pain reported by 63% of patients during first 
48h; severe pain in 12% within first 12h; incidence 
decreased over first 48h 
Rating Scale: VAS; not stated out of 10 
Nguyen et al. (2001) 
Canada 
RCT; N = 30  
Medication: Scalp nerve block (ropivacaine) 
70% of patients in saline group experienced moderate 
pain in first 48h post-op  
Rating Scale: VAS; scores 1.6-4.4 out of 10 
Rahimi et al. (2006) 
United States 
Prospective, single-blinded RCT; N = 27  
Medication: Oral narcotics vs. oral COX-2 
inhibitors 
Pain scores significantly higher in narcotics-alone group 
than COX-2 group (p = 0.003) 
Rating Scale: VAS; scores 2-5.3 out of 10 
Rahimi et al. (2010) 
United States 
Prospective, blinded RCT; N = 50  
Medication: Oral narcotics vs. tramadol 
 
Tramadol group had significantly lower pain scores than 
narcotics-alone group (p<0.005) 
Pain scores between groups significantly different (p = 
0.001435) 
Rating Scale: VAS; scores 1-8 (narcotics-along group), 
0-7 (tramadol group) out of 10 
Saringcarinkul and 
Boonsri (2008) 
Prospective, double-blind RCT; N =  50 33% of bupivacaine group pain free at 30 minutes; 
decreased to 4% at 8 hours 
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Thailand Medication: Incisional infiltration 
(bupivacaine) 
16% of control group pain free at 30 minutes; decreased 
to 4% at 1 hour 
Rating Scale: VNS; scores 2.5-3.5 out of 10 
Simon et al. (2011) 
Hungary 
Prospective RCT; N = 90  
Medication: Pre-operative oral diclofenac 
 
Significant difference in incidence of pre-operative 
headache between intervention and control groups (p = 
0.0045) 
77.7% experienced pain (first post-op day); 69.4% 
experienced pain (fifth post-op day) 
Rating Scale: VAS; scores 0-9 out of 10 
Sudheer et al. (2007) 
Wales 
Prospective RCT; N = 60  
Medication: PCA (morphine vs. tramadol) vs. 
intramuscular codeine 
 
4 patients did not require additional medication in first 
post-operative hour; 5 had severe pain necessitating 
withdrawal from study 
Less pain in morphine and codeine groups; significant 
residual pain noted in tramadol group 
Rating Scale: VRS; scores 0-10 out of 10 
Thibault et al. (2007) 
Canada 
Retrospective chart review; N = 299  
Medication: None tested 
24%  experienced mild pain, 51.5% moderate pain, and 
24.5% severe pain 
Overall prevalence of pain = 76% 
Rating Scale: VRS; scores unclear out of 10 
Ture et al. (2009) 
Turkey 
Prospective RCT; N = 80; 75 completed 
study 
Medication: Oral gabapentin vs. oral 
phenytoin 
 
Pain scores significantly higher in phenytoin group at 15, 
30, and 60 minutes (p < 0.001) 
Total morphine consumption significantly higher in 
phenytoin group (p = 0.01) 
Rating Scale: VAS; scores 0-4 out of 10 
Verchere et al. (2002) 
France 
Prospective, blind, RCT; N =64  Paracetamol-only group stopped quickly due to 
inadequate analgesia in 75% of patients 
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Medication: Paracetamol vs. paracetamol 
plus tramadol vs. paracetamol plus 
nalbuphine 
Rating Scale: VAS; scores 5-30 out of 100 
Williams, Pemberton 
and Leslie (2011) 
Australia 
Prospective, double-blind RCT; N = 100  
Medication: Intravenous parecoxib  
70% of control group and 61% of parecoxib group 
needed additional pain medication 
Rating Scale: VAS; scores 2-5 out of 10 
van der Zwan et al. 
(2005) 
The Netherlands 
Prospective, double-blind RCT; N =  50 
Medication: Remifentanil vs. fentanyl 
No significant difference in pain intensity between groups 
13 of remifentanil group (45%) required additional pain 
medication 
Rating Scale: VAS; scores 1-4 out of 10 
     RCT: randomized controlled trial; 4NRS: numerical rating scale; VAS: visual analogue scale; VRS: visual rating scale;  
     VNS: visual numeric scale. 
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  Table 2.2. Summary of Studies Using Theory of Unpleasant Symptoms Concepts 
Author, Year Influencing Factors Symptom Cluster Patient Performance 
Bala et al. (2006) • Length of surgery --- --- 
Batoz et al. (2009) --- • Vomiting 
• Agitation 
• Shivering  
• Hypertension  
--- 
Biswas and Bithal 
(2003) 
--- • Change in diastolic 
blood pressure 
--- 
Ducic et al. (2012) • Surgical site • Altered intracranial 
pressure 
• Altered quality of life 
• Development of 
persistent pain 
Ferber et al. (2000) --- --- • Change in systolic 
and/or diastolic blood 
pressure 
• Changes in heart rate 
• Changes in partial 
pressure of oxygen 
• Altered intracranial 
pressure 
Girard et al. (2010) --- • Nausea 
• Vomiting 
• Change in systolic 
blood pressure 
--- 
Grossman et al. 
(2007) 
--- • Nausea 
• Vomiting 
• Elevated blood 
pressure 
--- 
Irefin et al. (2003) • Gender 
• Surgical site 
• Nausea 
• Vomiting 
--- 
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Jellish et al. (2006) • Surgical approach 
• Gender 
• Nausea 
• Vomiting 
• Headache  
• Length of hospital stay 
• Patient satisfaction 
• Increased cost of 
medication used 
• Delayed discharge from 
hospital 
Jones et al. (2009) --- • Nausea 
• Vomiting 
• Sedation 
Law-Koune et al. 
(2005) 
--- • Nausea 
• Vomiting 
• Itching  
• Change in blood 
pressure 
• Bladder dysfunction 
• Sedation 
Magni et al. (2005) --- • Nausea 
• Vomiting 
• Shivering 
• Change in blood 
pressure 
• Change in heart rate 
• Change in Glasgow 
Coma Scale 
Magni et al. (2009) --- • Change in heart rate 
• Change in partial 
pressure of oxygen 
• Need for reintubation 
• Changes in Glasgow 
Coma Scale 
Morad et al. (2009) • Gender 
• Age 
• Surgical site 
• Surgical approach 
• Perioperative neural blockade 
• Nausea 
• Vomiting 
• Change in blood 
pressure 
• Change in heart rate 
• Change in mean arterial 
pressure 
• Neurological 
deterioration 
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Nair and Rajshekhar 
(2011) 
--- • Agitation 
• Sympathetic Nervous 
System (SNS) 
stimulation 
• Altered blood pressure 
• Brain swelling 
• Development of post-
operative complications 
• Increased length of 
hospital stay 
• Increased mortality rate 
Nguyen et al. (2001) • Incisional site --- --- 
Rahimi et al. (2006) • Surgical site • Nausea 
• Vomiting 
• Respiratory depression 
• Constipation 
• Neurological changes 
• Constipation  
• Altered mental status 
• Increased cost of 
medication used 
Rahimi et al. (2010) --- --- • Increased cost of 
medication used 
• Increased length of 
hospital stay 
Saringcarinkul and 
Boonsri (2008) 
--- • Nausea 
• Vomiting 
• Sedation 
• Change in Glasgow 
Coma Scale 
Simon et al. (2011) • Headache (presence prior to 
surgery increased post-
surgical pain) 
--- • Increased length of 
hospital stay 
Sudheer et al. (2007) • Surgical site (frontal 
associated with less pain) 
• Nausea 
• Vomiting 
• Change in partial 
pressure of oxygen 
--- 
Thibault et al. (2007) • Surgical site (frontal 
associated with less pain) 
 
• Nausea 
• Vomiting 
--- 
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• Age (increased age 
associated with lower pain 
scores) 
 
• Muscle reflection 
Ture et al. (2009) --- • Fatigue 
• Dizziness 
--- 
Verchere et al. (2002) --- • Nausea 
• Vomiting 
• Shivering 
• Risk of intracranial 
bleeding 
• Agitation  
• Hypertension  
--- 
Williams, Pemberton, 
and Leslie (2011) 
--- • Nausea 
• Vomiting 
• Sedation 
• Change in Glasgow 
Coma Scale 
van der Zwan et al. 
(2005) 
• Age (increasing age 
experienced more pain) 
• Surgical site 
• Nausea 
• Vomiting 
• Change in partial 
pressure of oxygen 
--- 
Total Studies 
Discussing Concept  
11 21 14 
NRS: numerical rating scale; VAS: visual analogue scale; VRS: visual rating scale; VNS: visual numeric scale. 
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CHAPTER THREE 
This chapter presents the results of a qualitative descriptive study of how 
persons diagnosed with a brain tumor who have had a craniotomy describe the quality of 
their pain during the post-surgical period. 
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Introduction 
 Brain tumors account for between 85% and 90% of central nervous system 
tumors diagnosed in the United States.142,143 Approximately 23,800 new cases of brain 
tumor were diagnosed in 2017.142,143 Recent scientific advances that have resulted in 
improvements in the diagnosis and treatment of brain tumors have increased one- and 
five-year survival rates.143-147 Approximately 90% of patients with brain tumors undergo 
craniotomies for treatment.148,149  
 Post-craniotomy pain is caused by a combination of skin incision and retraction 
and reflection of scalp muscles during surgery.150 The scalp contains both large and 
small diameter nerve fibers that transmit pain signals to the brain when stimulated.151 
Post-craniotomy pain involves mainly superficial nerves in the scalp, muscles, and soft 
tissue throughout the head although surgical manipulation of the dura mater during 
surgery may also result in pain.147 The nature of the pain experienced by post-
craniotomy patients may be related to the surgical site as incisions in the subtemporal or 
suboccipital region are likely to produce more pain.147 Head positioning during surgery 
may also play a role in the development of post-craniotomy pain.152   
Despite the common belief that craniotomies are less painful than other types of 
surgery, researchers have found that pain in post-craniotomy patients is often 
underestimated and up to 93% of post-craniotomy patients experience moderate to 
severe nociceptive pain.148,149,153 One recent review revealed that between 60% and 
96% of post-craniotomy patients experience pain within the first two days after surgery 
despite the use of analgesics, with multiple doses of medications frequently needed to 
reduce patients’ pain levels.154 Alternatively, one study found patients experienced 
minimal pain after brain surgery, but these patients were given intravenous opioid 
analgesics and were observed for only 24 hours after the surgery.155 While many studies 
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report that patients experience pain after surgery, the experience of such pain is poorly 
understood. 
 Because pain is salient during the post-surgical period of persons who have 
undergone a craniotomy, it is important that healthcare providers have a good 
understanding of the pain experience. One theory that  provides a broad-based 
perspective on symptom experiences, including pain, is the Theory of Unpleasant 
Symptoms (TOUS).156 According to the TOUS, symptoms can occur alone or 
simultaneously and can be caused by a single event (e.g., surgery) or develop over 
time.156 The TOUS identifies three components of the symptom experience: the 
symptom(s), the influencing factors that cause or affect the nature of the symptom(s), 
and the results or consequences of the symptom(s).156 Influencing factors include the 
physiologic, psychological, and situational factors that affect the experience of a 
symptom.156 Consequences include the effects of symptoms on functional and cognitive 
performance.156 The relationships among these three components are considered 
reciprocal rather than linear.156 The theory also outlines four symptom dimensions: 
intensity (i.e., severity), timing (i.e., duration and frequency), distress (i.e., amount of 
bother perceived), and quality (i.e., how the symptom feels).156 Each of these 
dimensions is distinct but interacts with the other dimensions to affect the overall 
symptom experience.156  
Some of the TOUS dimensions of pain have been studied in post-craniotomy 
patients. These studies, however, have primarily measured only the intensity and timing 
dimensions of pain. For example, an integrative review of 26 studies of post-craniotomy 
pain in brain tumor patients revealed that most studies were randomized controlled trials 
of pharmacological pain management.154 These studies measured primarily pain 
intensity and timing with visual analogue scales (VAS), numerical rating scales (NRS), 
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visual rating scales (VRS), or visual numeric scales (VNS)157-159 and did not address 
other dimensions of pain such as pain quality.  
In order to provide optimal pain care for patients with post-craniotomy pain, it is 
important to understand how patients experience not just the intensity and timing of the 
pain, but the quality as well. Because no studies have focused on this aspect of the pain 
experience in this population, the purpose of this study was to describe how persons 
diagnosed with a brain tumor who have had a craniotomy describe the quality of their 
pain during the post-surgical period. 
Methods 
Qualitative Description (QD) methods as outlined by Sandelowski guided the 
study.160 QD is a research approach frequently used in the health sciences to describe 
the experiences of persons who share a common health challenge in straight-forward 
terms. In order to generate information about the participants’ experiences, semi-
structured interviews are commonly used. Researchers use low inference analytic 
strategies to generate a surface description of participant experiences rather than more 
complex strategies that would be used to generate highly theoretical or conceptual 
renderings of the data. The product of QD is therefore a comprehensive summary of the 
main characteristics of the participants’ experiences that can be used to answer 
pragmatic practice questions. Because our aim was to provide straightforward 
description of how patients described the quality of their post-craniotomy pain, QD 
methods were the most suitable for this study. 
Setting  
Data were collected on the neurosurgical step-down unit of a large urban 
teaching hospital in the Midwest from February 2016 through December 2016. The 
hospital completes an average of 900 craniotomies for the treatment of brain tumors 
annually. The hospital’s neurosurgical practice provides service for patients throughout 
 54 
 
the Midwestern United States. The step-down unit has 23 beds with an average daily 
census of 23. Patients on this unit have undergone procedures for neurological illness 
and injuries, including craniotomies. They are clinically stable but have acute care needs 
that prevent transfer to medical-surgical acute care units. Standard post-surgical order 
sets that include a variety of recommended analgesics are utilized by the hospital’s 
neurosurgical practice. 
Inclusion and Exclusion Criteria 
Patients who had a craniotomy for the excision and removal of a brain tumor 
within the prior two weeks were recruited for the study. Other eligibility criteria including 
being age 21 years and older and speaking English fluently. Patients who were clinical 
unstable, actively psychotic, and or who had hearing, speech, or cognitive deficits that 
would interfere with full study participation were excluded.  
Recruitment   
 Prior to recruitment, institutional review board approval was obtained from the 
investigators’ university and a waiver of authorization was obtained for the use of 
protected health information for study recruitment. The medical records of consecutive 
patients hospitalized for the treatment of primary brain tumors were reviewed weekly by 
the unit’s Clinical Nurse Specialist (CNS) to determine study eligibility. The CNS 
generated a list of eligible patients, approached them, and obtained their verbal consent 
to be contacted by the study’s primary investigator. The primary investigator then 
approached and greeted potential participants. Using a standard script, the primary 
investigator obtained verbal consent to describe the study, confirm eligibility, and discuss 
study requirements. For those patients who agreed to participate, written informed 
consent for the interview and for review of medical records was obtained. Participants 
were informed that study participation was voluntary and that they could withdraw at any 
time. 
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Data Collection 
 
In order to describe the sample, the following data were collected from the 
participants’ medical records: (1) length of hospital stay; (2) participant age, gender, 
body mass index, and race/ ethnic background; (3) tumor type, grade, and location; (4) 
surgical approach, length of time, and head positioning; (5) documented pain ratings; (6) 
Glasgow Coma Scale ratings; (7) analgesics prescribed, dosages, and number of doses 
administered; (8) steroids prescribed, dosages, and number of doses administered; (9) 
prior pain history; and (10) prior opioid use. 
Interviews were conducted in the participants’ private hospital rooms by the 
primary investigator. The interview questions addressed the following topics: (a) how 
participants described their pain since surgery, (b) how they dealt with their pain, and (c) 
how healthcare providers managed their pain. For this study, prompts were used when 
needed to generate robust descriptions of participants’ pain quality. If the participants did 
not describe the quality of their pain in detail, the primary investigator asked them to do 
so with prompts such as, “Tell me more about what the pain felt like to you. How would 
you describe it?” Interviews were audio-recorded and transcribed by a professional 
transcriptionist. When participants requested, families were present for interviews and in 
a few instances contributed to the interview. Because family members had not provided 
consent for participation, their words were redacted from the transcripts.  
Data Analysis 
Descriptive statistics were used to describe the sample. Patient pain intensity 
ratings were summarized and averaged for each inpatient day. Patient Glasgow Coma 
Scale ratings were summarized and averaged for each inpatient day.  
The analysis team was made up of the primary investigator, a doctoral student in 
nursing; a senior nurse researcher with expertise in qualitative methods, and a senior 
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nurse researcher with expertise in oncology. Using standard content analytic 
procedures, the team analyzed the data in several stages.161    
Team members read through the transcripts multiple times in order to fully 
understand how the participants described the quality of their pain. The primary 
investigator highlighted and extracted text units (e.g., phrases, sentences, or stories) 
that captured how the participants described their pain, particularly its quality. The text 
units were coded with a word or phrase that captured their essence. The codes were 
verified by the other two team members. The codes were then categorized into different 
types of pain descriptors through team discussion and consensus. 
The primary investigator placed the codes into a case-by-topic table for data 
display.162 Cases were presented on the vertical axis and the categories were presented 
on horizontal axis. Codes were placed in appropriate cells. The codes in each column 
were summarized, and a narrative description of the categories in each column was 
written by the primary investigator. The narratives were confirmed by the other team 
members through a review of the transcripts.  
While the categories represented unique types of pain quality, many participants 
described several different types of pain that often changed over the post-surgical 
period. The team therefore selected three specific cases that exemplified the complexity 
and progression of post-craniotomy pain. A brief case summary was written for each of 
these participants with a focus on how they described the quality of their pain over the 
post-surgical period.  
Results 
Demographic and Medical Data 
 Twenty-eight patients met study criteria and agreed to participate. One patient 
who initially agreed to participate was not interviewed because she was noted to be 
confused after providing consent, and none of her data were used in the study. Of the 
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remaining 27 participants, the medical record for one participant who was interviewed 
could not be accessed. Therefore, demographic and medical data are presented for 26 
patients, while the qualitative findings are based on interviews with 27 patients.  
Patients were interviewed between 2 and 11 days after surgery. Demographic 
and medical data were collected for 26 of the patients interviewed and are presented in 
Table 3.1. Participants were between the ages of 21 and 83 years. Sixteen participants 
were women, and 11 were men. Twenty-six of the participants were Caucasian, and one 
was African-American. The participants’ lengths of hospital stay were between 3 and 13 
days. Most participants had no history of opioid use and most had no prior pain history. 
 As seen in Table 3.1, the participant tumor types were diverse with glioma/ 
glioblastoma/ oligodendroglioma/ oligodendroma and meningioma being the most 
common. All grades of tumors were represented with grade 1 tumors being the most 
common. The location of tumors included the frontal, frontotemporal, temporal, and 
posterior fossa regions. The participants’ tumors were located fairly equally in the right 
and left hemispheres. The length of surgeries ranged between 150 and 984 minutes, an 
anterior approach was used in more than half of the surgeries, and the majority of 
participants received sedation. The most frequently prescribed post-surgical analgesics 
were fentanyl, hydrocodone-acetaminophen, acetaminophen, oxycodone-
acetaminophen, and hydromorphone. Most of the participants were also prescribed 
dexamethasone.  
Interviews 
 The interviews lasted between 7 and 50 minutes and averaged 30 minutes. The 
majority of participants were oriented and alert, although a few were oriented but 
lethargic. Some participants provided elaborate, in-depth descriptions of their pain 
quality, while others needed more interviewer probing to describe their pain. Many 
participants reported their pain had subsided, while a few were in pain during the 
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interview. The participants’ demeanor varied during the interviews. Most were in good 
spirits and eager to participate whereas some appeared irritable and frustrated and 
questioned why their pain was important to discuss. A few were tearful. 
Quality of Pain 
 The participants described the quality of their pain with six different types of 
descriptors. We labeled the six types of pain quality descriptors as follows: pain as 
pressure, pain as tender or sore, pain as stabbing, pain as throbbing, pain as jarring, 
and pain as itching. Because we used common word use definitions to categorize and 
label the participants’ pain quality descriptors into the six types, these definitions are 
included below. In some cases, the participants used the word we chose as a label, 
whereas in other cases they described their pain with different words that conveyed the 
same or similar pain quality. While the focus of this analysis was on the quality of the 
participants’ pain, for each pain quality type we discuss relevant participant comments 
about the intensity, timing, or location of that type of pain. A few participants did not 
describe the quality of their pain, but instead focused only on the intensity, timing, or 
location of their pain. 
Pain as Pressure 
Eight participants described the quality of their pain as pressure. Pressure in 
common usage is defined as “the application of force to something by something in 
direct contact with it.”163 Most of these pain descriptions included the word pressure. A 
63-year-old Caucasian woman who had surgery for a right temporal mass said, “It feels 
like a lot of pressure behind my forehead. It feels like a lot of pressure and it’s pushing in 
there or like it’s full and it can’t get any fuller.” Others did not use the word pressure but 
described a sensation of pressure as being squeezed. A 54-year-old Caucasian woman 
who had surgery for an oligodendroma said it was like having her head in a vise and 
having a screw put in. Several of the participants indicated that the pressure was severe; 
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they described it as “lots and lots of pressure,” “intense pressure pain,” or pressure that 
“really, really hurts.” The participant quoted above who described the pain as having her 
head put in a vise also said the pressure “makes you feel like your head will explode.” 
Most of the participants described the pressure as constant, but one participant 
experienced it only when she vomited. Some described the pressure throughout their 
heads but others described it as localized, such as in the forehead or at the site of the 
incision.  
Pain as Tender or Sore 
 Eight participants described the quality of their pain as tender or sore. Tender is 
defined in common usage as “sensitive to touch or palpation,”164 and sore as “physically 
tender (as from overuse or injury).”165 Many of the participants described their pain using 
the words tender or sore. A 69-year-old Caucasian woman who had surgery for a 
glioblastoma stated, “When I let my head down, it is a little tender.” Several indicated 
they only felt pain upon touch. A 48-year-old Caucasian woman who had surgery for a 
cerebral meningioma said, “Right now I am sore and if I touch it, it hurts.” Others 
described tenderness due to bruising or swelling. This type of pain was usually 
described as mild or manageable and occurred occasionally. While the soreness or 
tenderness was typically at the incision site, it could occur elsewhere as well. An 83-
year-old Caucasian man who had surgery for a glioblastoma described several of the 
common elements of pain as tender or sore: 
[The pain is] very minor here right where I had pain before. And I have 
pain now when I touch it. There’s not much pain here, in fact, it’s less. It’s 
not throbbing. I have a sore spot which is somewhat like before. I’ve got 
pain in my brain. Now it’s sore and it’s only sore because I touch it. 
 
Pain as Stabbing 
 Five participants described the quality of their pain as sharp or stabbing. Sharp in 
common usage is defined as “severe or harsh” or “clear in outline or detail,” whereas 
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stabbing is defined as “a sudden sharp feeling.”166-167 Most of these participants’ pain 
descriptions included the word sharp. A 34-year-old African-American woman who had 
surgery for a glioblastoma said the pain felt like “a very sharp, stiff pain spiking in and 
out.” A 28-year-old Caucasian man who had surgery for a low-grade glioma described 
the onset of the pain in this way: 
It starts to feel like I’m getting stabbed with needles in the side of my face 
and my head. If it goes on, I start to [also] get a headache…. It just feels 
like I’m getting stabbed and then it gets a little tingle. It kind of feels like 
I’m getting stabbed with a pin and then it almost feels like it’s bleeding. 
 
The timing of the sharp or stabbing pain varied. Some participants said the pain 
was constant and on-going, whereas one said it was occasional and then went away. 
The location also varied as some participants said the sharp or stabbing pain was “all 
over,” whereas one said it was localized to the incision site. 
Pain as Throbbing 
Four participants described the quality of their pain as throbbing. In common 
usage, throbbing is defined as “pulsating or pounding rhythmically.”168 All of the 
participants in this group used the word throbbing to describe their pain. A 21-year-old 
Caucasian man who had surgery for a schwannoma said when the pain really hurt, it 
throbbed. A 36-year-old Caucasian woman who had surgery for a metastatic brain tumor 
described the pain like a heartbeat. All four participants indicated that the throbbing pain 
was intense. A 34-year-old African-American woman who had surgery for a glioblastoma 
stated, “It [the pain] was excruciating upon waking up. The pain was a shock to me. I felt 
like I had taken an axe to the head. It was a throbbing pain all around the incision.” One 
participant said the throbbing pain occurred upon coughing, and another said the 
throbbing pain was on-going. Some of these participants said the pain was localized to 
the site of the incision.  
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Pain as Jarring 
 Four participants described the quality of their pain as jarring. In common usage, 
to jar is defined as “to have a harsh or unpleasant effect on someone or something,” or 
as “to hit or shake (something) forcefully.”169 Only one of these four participants used the 
word jarring to describe the pain. This participant, a 73-year-old Caucasian woman who 
had surgery for a cerebral meningioma, said, “My head was fine until I coughed the first 
time and then it just jarred and would hurt so bad.” The others used descriptions that are 
consistent with the definition of jarring presented above. They discussed feeling like they 
were slapped, slammed, or hit on the side of the head. A 22-year-old Caucasian man 
who had surgery for metastatic brain cancer stated, “Imagine those weird curvy bike 
racks and slamming your head into one of those and it being this incision.” For some the 
jarring pain occurred following sudden movements such as coughing or bending over.  
Pain as Itching 
 Four participants described the quality of their pain as itching. In common usage, 
to itch is defined as “to have or produce an unpleasant feeling on your skin or inside your 
mouth, nose, etc. that makes you want to scratch.”170 Most of the participants in this 
category used the word itches when describing the quality of their pain. The 22-year-old 
man mentioned above said, “At its best, it [his pain] itches.” One participant did not use 
the word itch but instead described needing to scratch. Although itching might not be 
considered pain, these participants deemed it so and described it as particularly 
bothersome and often unremitting. The 73-year-old woman mentioned above described 
the common elements of pain as itching: 
My forehead hurts just a little bit and I just wanna get in my head and dig. 
I have all this and it’s real heavy and I just wanna get in there and 
[scratch]. 
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Pain Descriptions Limited to Severity, Location, and Timing  
All participants did not provide descriptions of the quality of their pain. Despite 
multiple queries by the interviewer about “what the pain felt like,” some participants only 
described the intensity, timing, or location of their pain. Descriptions of pain intensity 
ranged from mild discomfort to severe and excruciating pain. A 50-year-old Caucasian 
man who had surgery for a glioblastoma described his pain as tolerable. In contrast, a 
59-year-old Caucasian woman who had surgery for an acoustic neuroma stated that she 
was crying because her pain was so horrible. Descriptions of the timing of the pain 
ranged from intermittent to constant and most participants indicated the pain decreased 
over time. A 34-year-old Caucasian woman who had surgery for a vestibular 
schwannoma described her pain as occurring “every now and then,” whereas the 59-
year-old woman mentioned above described her pain as constant. While for her the pain 
lessened over time, she stated, “It’s still there if you don’t take anything.” The 
participants described the location of their pain mostly as occurring in the same location 
as the surgery, although for some the pain was generalized throughout their heads.  
Case Examples of Descriptions of Pain Quality 
While the participants described the quality of their post-craniotomy pain with the 
six basic types of descriptions discussed above, many portrayed their pain using several 
of these descriptors. Examining individual cases revealed the multi-faceted nature of the 
post-craniotomy pain experience. Below we present three participants whose 
descriptions of their pain were particularly complex or dynamic. We refer to these 
participants as Participant 1, 2, and 3. 
Participant 1 
 Participant 1 was a 36-year-old Caucasian woman who had surgery for 
metastatic brain cancer and had been in the hospital for five days at the time of the 
interview. She had surgery on the left side of her skull using an anterior approach and 
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had general anesthesia. After surgery, she had been prescribed various narcotics for 
post-surgical pain, including hydromorphone, oxycodone, morphine, fentanyl, and 
oxycodone with acetaminophen. Some of the analgesics were ordered for as frequently 
as every two hours, while others were to be given once daily. She was also prescribed 
daily doses of hydrocortisone to control post-surgical swelling. She had several 
surgeries in her lifetime but described this surgery as one of the most painful.  
Participant 1 described the quality of her pain in multiple ways, offering vivid 
descriptions of it throughout her hospital stay. She initially described her pain in a way 
that was consistent with what we have labeled as jarring pain. She said, 
I didn’t realize that I was in pain until I bent over to grab something off the 
floor, just a wrapper, pick it up, throw it away. Even bending at the knees 
still hurt, you just squat down and bend, you know, if you got up too 
quickly that hurts. Obviously, if someone hits you in the head with 
something, it hurts. Coughing. I coughed last night and I felt like someone 
took a cinder block and broke it over the top of my head. 
 
She later described the pain in the following way: “It was the same as like there’s 
little tiny men going in there and ripping open your head. And pounding your head with 
little hammers. It sounds crazy but it hurts.” 
In another instance, she described her pain as throbbing. She said,  
I’ve laid on the back of my head [which is close to the incision] and it’s not 
a very comfortable feeling. The pain is more of a throbbing. It’s like you 
could feel your heartbeat. And the more you feel your heartbeat, the 
worse the pain gets. 
 
She described her pain when she walked in yet another way. In this instance, 
she described a “vibrating” pain that went up her spine and that “kind of hurt.”   
One of her descriptions combined several of the types of pain quality. She said,  
They’re [types of pain] all different. They all feel like you could feel your 
heartbeat, but when I cough really hard, it felt like my head almost split 
open like the incision, that’s what it felt like. It was a hard cough and it 
threw me for a loop. It hurt from my head down to the middle of my neck, 
it hurt. So that’s pretty painful. 
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Participant 2 
Participant 2 was a 48-year-old Caucasian woman who had surgery for a 
cerebral meningioma and had been in the hospital for four days at the time of the 
interview. She had surgery on the left side of her skull using an anterior approach and 
had general anesthesia. After surgery, she had been prescribed various narcotics for 
post-surgical pain, including hydromorphone, fentanyl, and hydrocodone with 
acetaminophen. Some of the analgesics were ordered for as often as every five minutes, 
while others were ordered for every four hours. She was also prescribed daily doses of 
dexamethasone to control post-surgical swelling. 
Participant 2 described a pain trajectory that was similar to other participants as 
she had severe pain immediately after surgery and pain that lessened over time 
throughout the post-surgical period. When she discussed her pain immediately after 
surgery, she did not describe the quality of her pain but instead focused on its intensity. 
She stated, 
The first day was a killer. Oh, my, God. The first day of surgery, I was 
demanding pain medicine every two minutes because it hurt that bad. 
The pain was extremely excruciating. It was horrible. 
 
Later in the interview, she again stressed the intensity of her pain upon waking from 
surgery: “On a scale of one to ten, it was a twenty. It was horrid. It would not go away. It 
was just bad. The first day was bad.”   
When the interviewer inquired about the quality of her pain right after surgery, 
Participant 2 likened it to a migraine. She stated, 
Migraines run in my family bad and that’s what it felt like to me, was 
having a severe migraine attack. It felt so bad that I felt sick to my 
stomach like I could throw up. I never did, but that’s how I felt, like I could 
have possibly thrown up. The pain was that bad. 
 
As her recovery progressed, however, her pain began to improve with 
medication. When she described her pain the day following surgery, she said,  
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It just started stair stepping down from there. Of course, the next day they 
kept me on a routine schedule where I didn’t have to worry about the pain 
level. 
 
When the interviewer asked her to describe the quality of this lesser pain, she initially 
described the intensity and stated that she never rated it more than a two or a three on a 
scale of ten. She then said, 
The pain was just like a small headache. Just a general headache that 
you’d get through the day, that you might need to take a couple of 
Tylenols or something to get rid of. Nothing major. Just like a small 
headache. Just a general headache that you’d get throughout the day. 
And it mostly hurts on this side that he took the tumor from. I’m tender 
from where I’m bruised and I’m swollen but I’m not hurting from like a 
headache or anything. 
 
By the time she was interviewed on the third day after surgery, her pain had 
decreased and she rated it as a “one on a scale of ten.” When describing this pain, she 
stated, 
It’s tender, but it’s nothing like having the headaches. The headaches 
were totally different than having the little pain from where it’s bruised. So, 
it is different pain. The headaches were like being hit by a Mack truck. 
 
Participant 3 
 Participant 3 was a 58-year-old Caucasian woman who had surgery for a 
meningioma and who had been in the hospital for 4 days at the time of the interview. 
She had surgery on the right side of her skull using a posterior approach and had 
general anesthesia. After surgery, she had been prescribed fentanyl and oxycodone with 
acetaminophen. The oxycodone with acetaminophen was ordered for as frequently as 
every four hours, while the fentanyl was ordered as a one-time dose. She was also 
prescribed dexamethasone to control post-surgical swelling.  
Participant 3 also described the quality of her pain in multiple ways as it changed 
over the course of her hospital stay. She initially described her pain in a way that was 
consistent with what we have labeled as pressure. She said, 
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It was pretty bad. It was like having the tumor all over again. Because of 
the pressure and the headache, it was pretty bad. 
 
Similar to the other participants, the quality of her pain changed during the post-
surgical period. She described her pain later in a way that is consistent with what we 
have labeled itching. For her, this kind of pain was more troublesome than the other 
kinds of pain she experienced. She stated,  
The itching and swelling has been the worst. It was really starting to itch 
and to bother me. I was itching all over from it. 
 
By the third day after her surgery when she was interviewed, her pain had 
decreased and she described it in a way consistent with what we have labeled tender or 
sore. She said of the pain at that point, 
I don’t think I’ve had much pain, so today has been pretty good except for 
when I get up to go to the bathroom. It still kind of hurts. I can still feel a 
little and I wouldn’t know if that’s because my neck has all swelled back 
there. It kind of gives the headache a little bit but it’s tolerable. It’s not like 
it was… It hasn’t been really that bad today. 
 
Discussion 
The majority of the participants reported some pain following their craniotomies. 
Based on the participants’ descriptions, we identified and labeled six types of pain 
quality: pain as pressure, pain as tender or sore, pain as stabbing, pain as throbbing, 
pain as jarring, and pain as itching. Many participants gave vivid and complex 
descriptions of their pain quality, whereas a few gave simple or minimal descriptions and 
instead focused on the intensity and timing of their pain. Several participants described 
their pain in ways that varied significantly across the post-surgical period.  
While no other studies to our knowledge have provided in-depth descriptions of 
pain quality in patients who had craniotomies, a few studies did measure the quality of 
pain following other types of surgery, primarily using the McGill Pain Questionnaire 
(MPQ).171-173 In addition to measuring intensity and timing of pain, the MPQ provides 
sensory, affective, and evaluative word descriptors to capture respondents’ subjective 
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pain experiences.174-176 Seventy-eight adjectives are divided into 20 groups and 
respondents are asked to pick the single adjective in each group that best applies to 
their current pain in response to the question “What does your pain feel like?”  For 
example, from the group labeled “temporal,” respondents would pick from among the 
following adjectives: flickering, quivering, pulsing, throbbing, beating, or pounding.174-176  
From the group labeled “spatial,” respondents would pick from among the following 
adjectives: jumping, flashing, or shooting. Each adjective is assigned an intensity point 
that can be summed for each dimension and for a total cumulative score.174-176 For 
example, in a study of pain after surgery for an inguinal hernia, the researchers reported 
that  participants most frequently selected the MPQ pain descriptors of aching, hot or 
burning, or heavy.172 In a study of patients following  percutaneous transluminal coronary 
angioplasty, patients with nonspecific pain selected fewer and qualitatively weaker pain 
descriptors compared to patients with ischemic pain.171 In a study of patients following 
breast reconstruction, participants who described sensory pain selected qualitatively 
stronger descriptors than those that described affective pain.173  
 The pain quality descriptors provided by our participants resonated with several 
of the adjectives that comprise the MPQ.174-176 Pain as pressure, for example, is 
analogous to the MPQ descriptors of pressing and crushing; pain as tender or sore to 
the MPQ descriptors of dull, sore, and tender; pain as stabbing to the MPQ descriptors 
of boring, drilling, stabbing, and lancinating; pain as throbbing to the MPQ descriptors of 
pulsing, throbbing, beating, and pounding; pain as jarring to the MPQ descriptors of 
jumping or flashing; and pain as itching to the MPQ descriptor of itchy. Several of the 
groups of adjectives on the MPQ, however, were not mentioned by our participants. For 
example, our participants did not provide descriptions of pain that were considered 
sensory pain (e.g., cool, cold, freezing) or tension pain (e.g. tiring, exhausting) on the 
MPQ.  
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Although the MPQ,174-176 which includes a wide variety of pain quality 
descriptions and allows for quantification of pain quality, has been used to describe post-
surgical acute pain in several studies, our study adds to the literature by providing an in-
depth description of pain quality in post-craniotomy patients. Using a narrative approach, 
we were able to capitalize on the unique and vivid descriptions the participants used to 
describe their pain experience in their own words to provide a rich depiction of the 
participants’ subjective experiences of pain. Such descriptions can add to measures of 
pain intensity and timing to capture the multi-dimensional nature of post-surgical pain in 
this population.  
Limitations 
 These findings are best understood in the context of several limitations. The main 
study limitation was that our interviews were conducted at a single time point. In many 
cases, this generated robust descriptions of pain quality, including how it changed over 
time, but in some cases, participants had difficulty articulating the nature of the quality of 
their pain or identifying how it changed from day to day. We recognize that we likely 
would have obtained more detailed descriptions of the quality of the participants’ pain 
had we queried them regularly over the post-surgical period. This would have also 
allowed us to triangulate numerical measures of pain intensity with narrative descriptions 
of pain quality. Moreover, because our participants were post-surgical patients, all of 
whom had had anesthesia and most of whom were often taking pain medications, it is 
possible that their memories of their pain experiences may have been impaired and we 
may not have fully captured the breadth of possible pain quality descriptions in our 
interviews.  
Because our study was conducted on a single unit at a large urban teaching 
hospital, it is possible that participants did not experience a full range of pain quality 
because their pain was managed with a standard protocol. Also, although brain tumors 
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occur more frequently in non-Hispanic whites than in other minorities,2 minorities were 
nonetheless under-represented in our sample. This is problematic because research 
suggests that different ethnic groups respond to pain differently. Some studies indicate, 
for example, that Hispanics and African-Americans are more likely to report severe pain 
than Caucasians,177,178 Asian Americans are more likely to report less pain or to hide 
their pain than other groups,177 and Native Americans have a higher prevalence of pain 
symptoms compared to the general US population.177,178 
Future Research 
 In order to advance our understanding of how pain quality changes over time in 
this population, we suggest conducting studies at multiple time points after surgery as 
has been done in studies of pain intensity.179,180 In addition, conducting interviews at 
multiple study sites could help generate a broader range of pain quality descriptions that 
may have been precluded by the routine pain management practices on our single study 
unit. Moreover, due to differences in how ethnic minorities experience pain quality,177,178 
using a more diverse sample would enable comparison of pain quality descriptors 
among groups. A larger sample would allow for exploration of the impact that other 
factors, such as age and type of surgery, might have on the quality of pain. Research 
that explores associations between pain quality descriptors, numerical pain ratings, and 
medication doses and frequencies would provide a more comprehensive description of 
the pain experiences in this population.  
Clinical Implications 
Despite the limitations of our study, the findings do suggest some clinical 
implications. Because the descriptions of pain quality in patients’ own words provide a 
different understanding of their post-surgical experiences than do numerical pain ratings, 
clinicians should engage patients in discussions about their unique pain experiences. 
Clinicians could initiate these discussions with the following questions: How would you 
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describe the pain?; How does the pain feel?; or What is the pain like to you? Asking 
questions such as this will result in a more comprehensive assessment of patients’ pain. 
Providing patients an opportunity to describe the quality of their pain might reveal 
experiences that are quite bothersome although not necessarily severe, such as itching 
pain. A better understanding of the quality of pain might also suggest some ways to tailor 
non-pharmaceutical pain management strategies. Pain as jarring, for example, may 
indicate a need to limit exertion during post-surgical activities such as physical therapy, 
pain as pressure may suggest the need to reduce swelling, and pain as itching may call 
for topical solutions.  
Conclusion 
 Pain quality is a critical dimension of the pain experience but it is not frequently 
studied. The quality of pain experienced by post-craniotomy patients varies considerably 
and influences their post-surgical experience in important ways. Our classification of six 
types of pain quality descriptors in post-craniotomy patients, if further developed and 
validated, could advance our understanding of the subjective experiences of pain in this 
population and might possibly provide a foundation for the improvement of pain care for 
patients who have surgery for tumor removal.  
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Table 3.1. Demographic and Medical Record Data (n=26) 
 
 n % 
Age  20-29 years 3 11.5 
 30-39 3 11.5 
 40-49 4 15.4 
 50-59 4 15.4 
 60-69 8 30.8 
 70-79 3 11.5 
 80-89 1 3.8 
Gender Female 15 57.7 
Male 11 42.3 
Race Caucasian 25 96.2 
African-American 1 3.8 
Tumor type Glioma/ 
Glioblastoma/ 
Oligodendroglioma/ 
Oligodendroma 
8 30.8 
Meningioma 6 23.1 
Schwannoma 5 19.2 
Carcinoma 3 11.5  
Hemangioblastoma 2 7.7 
Ependyoma 1 3.8 
Hamartoma 1 3.8 
Tumor grade I  11 42.3 
II 2 7.7 
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III 2 7.7 
IV 3 11.5 
Not stated 8 30.8 
Tumor location Frontal 4 15.2 
Frontotemporal 3 11.5 
Temporal  3 11.5 
Posterior fossa  3 11.5 
Skull base  2 7.7 
Suboccipital  2 7.7 
Cerebellar  2 7.7 
Vestibular  1 3.8 
Supratentorial 1 3.8 
Parieto-occipital  1 3.8 
Parietal 1 3.8 
Not stated 3 11.5 
Tumor 
Hemisphere 
Right 15 57.7 
Left 11 42.3 
Surgical 
Approach 
Anterior 
 
25 96.2 
Posterior 1 3.8 
Type of 
craniotomy 
Sedated  
 
17 65.4 
Awake 9 34.6 
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Analgesics 
prescribed1 
Fentanyl  23 88.5 
Hydrocodone-
acetaminophen  
15 57.7 
Acetaminophen 14 53.8 
Oxycodone-
acetaminophen 
9 34.6 
Hydromorphone 6 23.1 
Morphine 5 19.2 
Oxycodone 4 15.4 
Ibuprofen 2 7.7 
Lidoderm 1 3.8 
Acetaminophen-
codeine  
1 3.8 
None 1 3.8 
Steroids 
prescribed 
Dexamethasone 22 84.6 
Hydrocortisone 1 3.8 
None 3 11.5 
Prior pain 
history 
No  24 92.3 
Yes 2 7.7 
Prior opioid 
use 
No 25 96.2 
Yes 1 3.8 
 
 
 
                                                           
1 The total number of analgesics prescribed does not add up to 26 because many patients were 
prescribed more than one medication. 
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CHAPTER FOUR 
 This chapter presents the results of a qualitative descriptive analysis of how 
persons who have undergone a craniotomy for excision and removal of a brain tumor 
experience pain management during the post-surgical period. 
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Introduction 
 
In 2017 in the United States, approximately 23,800 estimated new cases of brain 
tumor were diagnosed,181,182 and most of these persons underwent a craniotomy for 
tumor removal.182 Pain during the post-surgical period is a significant clinical concern for 
some patients who undergo craniotomies. Post-craniotomy pain is caused by the 
incision of the skin and the retraction and reflection of the muscles of the scalp, which is 
profusely innervated by large and small diameter nerve fibers.183,184, Post-craniotomy 
pain is mainly superficial in origin and likely involves the scalp, muscles, and soft tissue 
of the head, although manipulation of the dura mater covering the brain can also trigger 
painful sensations.185 The nature of the pain experienced by post-craniotomy patients is 
related to the surgical site, with incisions in the subtemporal or suboccipital region 
producing higher incidences of pain.185 
  Although the percentage of post-craniotomy patients who experience pain within 
the first two days after surgery is found to be as high as 60-96% despite the use of 
analgesics, research suggests that healthcare providers may undertreat this pain as they 
mistakenly believe that craniotomies are less painful than other types of surgery due to 
lack of innervation in the brain.185-187 In addition, prescribers may be reluctant to 
prescribe opioids for post-craniotomy pain because these medications can cause 
decreased or altered levels of consciousness, thereby masking important neurological 
changes, or because they can cause respiratory depression leading to increased 
intracranial pressure and compromised cerebral circulation.194 Moreover, nausea and 
vomiting resulting from analgesic administration can increase blood pressure and 
contribute to an increased risk of aspiration.188,189  Effective pain management of post-
craniotomy pain may also be compromised because few non-pharmacologic strategies 
for pain management have been developed and tested in this population.190,191 
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Pain care for craniotomy patients in the post-surgical period typically includes the 
use of  opioids,185 alpha-2 adrenergic agonists191 such as dexmedetomidine,192 and 
adjuvant pain medications.193,194 During surgery, the use of scalp nerve blocks may 
decrease the need for additional analgesia after surgery and increase the time between 
the end of surgery and post-operative analgesic administration,195-199 while techniques 
such as wound infiltration can result in temporary decreases in pain after surgery.200  
The addition of atypical analgesics, such as COX-2 inhibitors, to a post-surgical pain 
regimen may decrease side effects and increase earlier mobilization, thereby reducing 
hospital stay and associated costs.188,201,202 
Untreated or undertreated pain during the post-surgical period can negatively 
affect a number of health outcomes. First, unabated pain following surgery may cause 
permanent neurological changes leading to the development of persistent neuropathic 
pain.203-214 In addition, uncontrolled pain following a craniotomy may cause agitation and 
sympathetic stimulation resulting in increased blood pressure and swelling.191 Moreover, 
acute post-craniotomy pain in brain tumor patients is associated with greater healthcare 
burden including longer lengths of stay and higher costs of hospitalization,191 delayed 
mobilization,191 higher rates of disability, and poor perceived quality of life due to 
increased anxiety and depression.187,204-206  
Despite calls for the development of better strategies to manage post-craniotomy 
pain, little is known about patient perspectives on pain care following surgery. Pain care 
improvement initiatives would be enhanced with a better understanding of the pain 
management experience as described by post-craniotomy patients in their own words. 
The purpose of this study was to describe how persons who have undergone a 
craniotomy for excision and removal of a brain tumor experience pain management 
during the post-surgical period.  
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Methods 
Qualitative Description (QD) methods, as described by Sandelowski,207 guided 
this research. QD is the method of choice when the goal of the research is to summarize 
the experiences of a group in common, everyday terms. Often semi-structured 
interviews are used to generate information about participants’ experiences.207 When 
using QD, researchers use low inference analytic strategies such as standard content 
analysis to summarize data rather than generating abstract concepts from the data 
set.207 The outcome of QD is a straightforward summary of the data presented in such a 
way that it answers important pragmatic practice questions. Because we aimed to 
provide a straightforward description of patients’ pain management experiences 
following craniotomy, QD methods were most applicable to this study.  
Setting  
 
Data were collected from February 2016 through December 2016 at an urban 
teaching hospital, where an average of 900 craniotomies for the treatment of brain tumor 
are performed annually. The neurosurgical practice of the hospital draws patients from 
throughout the Midwestern United States. The study was conducted on the 
neurosurgical step-down unit, where patients who have undergone procedures for 
neurological injuries and illnesses including craniotomies are treated. The neurosurgical 
step-down unit is a 23-bed unit with an average daily census of 23. Patients transferred 
to this unit are clinically stable with acute care needs that prevent them from being 
transferred to a medical-surgical acute care unit. Standard post-operative pain 
medication order sets, which include a variety of recommended oral and intravenous 
analgesics, are used on the step-down unit. 
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Inclusion and Exclusion Criteria 
Patients who had a craniotomy for the excision and removal of a brain tumor 
within the prior two weeks were recruited for the study. Other eligibility criteria including 
being age 21 years and older and speaking English fluently. Patients who were clinical 
unstable, actively psychotic, and or who had hearing, speech, or cognitive deficits that 
would interfere with full study participation were excluded.  
Recruitment 
Institutional review board approval was obtained from the investigators’ 
university, and a waiver of authorization to use protected health information for study 
recruitment was obtained from the hospital. During each week of recruitment, the 
medical records of consecutive patients who had been hospitalized for the treatment of 
primary brain tumor were reviewed by the clinical nurse specialist (CNS) on the unit to 
determine eligibility. The CNS generated a list of eligible patients and approached them 
to obtain their verbal consent to be contacted by the primary investigator (first author) to 
discuss the study. The primary investigator approached and greeted potential 
participants, and, using a standard script, described the study, confirmed eligibility, and 
discussed the study requirements. Written informed consent for the interview and review 
of medical records was obtained from patients who agreed to participate. Participants 
were informed that their participation was voluntary and that they could choose to 
withdraw from the study at any time.  
Data Collection 
In order to fully describe the sample, the following data were collected from the 
participants’ medical records: (1) length of hospital stay; (2) participant age, gender, 
body mass index, and race/ ethnic background; (3) tumor type, grade, and location; (4) 
surgical approach, length of time, and head positioning; (5) documented pain ratings; (6) 
Glasgow Coma Scale ratings; (7) analgesics prescribed, dosages, and number of doses 
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administered; (8) steroids prescribed, dosages, and number of doses administered; (9) 
prior pain history; and (10) prior opioid use.  
All interviews were conducted in the participants’ hospital rooms by the primary 
investigator. The interviews included questions about (a) how the participants described 
their pain since surgery, (b) how they dealt with their pain, and (c) how their healthcare 
providers managed their pain. The ways in which the patients described the quality of 
their pain is described elsewhere.208 For this study, prompts were used to obtain robust 
descriptions of their pain management experiences. For example, whenever possible, 
the participants were asked to describe specific interactions with providers related to 
pain care. The interviews were audio-recorded and transcribed by a professional 
transcriptionist. A few family members were present for the interviews and, in some 
instances, their comments were recorded. These comments were redacted from the 
transcripts as family members had not consented to participate in the study. 
Data Analysis 
 Demographic and medical data were described with frequency counts and 
percentages. Pain intensity ratings and Glasgow Coma Scale ratings were each 
summarized and averaged for each inpatient day. For the qualitative analysis, the 
principal investigator and two senior nurse researchers, one with expertise in qualitative 
methods and one with expertise in oncology, comprised the analysis team. The data 
were analyzed in four stages using standard content analytic procedures.209 First, all 
team members read through the transcripts several times to obtain a thorough 
understanding of the participants’ overall pain management experiences. Second, the 
primary investigator highlighted and extracted text units (e.g., phrases, sentences, or 
stories) related to the participants’ pain and pain management experiences. These text 
units were each given a code, which is a word or short phrase that captured the essence 
of the data. The other team members verified the codes. Third, the primary investigator 
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created a case-by-topic table.210 The cases were presented on the vertical axis and 
topics of interest related to pain management (e.g., descriptions of pain, actions taking 
by providers, self-management of pain) were placed on the horizontal axis. Each code 
was placed in the appropriate cell. The codes in each column were summarized, and 
through team discussion and consensus, categories were developed. Fourth, a narrative 
description of the categories in each column was written by the principal investigator and 
confirmed by the other team members. 
Results 
Demographic and Medical Data 
 Twenty-eight patients met criteria and agreed to participate in the study. Because 
one patient appeared somewhat confused after she provided consent, she was not 
interviewed and her demographic/medical data were not used. The medical record of 
another patient who was interviewed could not be located. The findings reported here 
therefore are based on demographic/medical data from 26 patients (Table 4.1) but 
narrative interview data from 27 patients.  
Participants were between the ages of 21 and 83 years. As seen in Table 4.1, 
more women than men participated. Most participants were Caucasian; one participant 
was African-American. Participants’ length of hospital stay were between 3 and 13 days. 
The majority of participants had no prior pain history or history of opioid use. 
The most common tumor types were glioma/ glioblastoma/ oligodendroglioma/ 
oligodendroma and meningioma. Participants were diagnosed with all grades of tumors, 
with grade 1 being the most common. The tumor grade of 8 participants was not listed in 
the medical record. The most common tumor sites were frontal, frontotemporal, 
temporal, and posterior fossa. The tumors were located equally in the left and right 
hemispheres. The surgeries lasted between 150 and 984 minutes, and the majority of 
surgeries used an anterior approach. Most participants underwent a sedated rather than 
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an awake surgery. The most frequently prescribed analgesics included fentanyl; 
hydrocodone-acetaminophen; acetaminophen; oxycodone-acetaminophen; and 
hydromorphone. Most participants were also prescribed dexamethasone. 
Interviews 
The interviews lasted between 7 and 50 minutes with an average of 30 minutes. 
Most of the participants were oriented and alert. A few were lethargic or slightly confused 
but still able to participate in the interview. Some participants provided many details and 
gave elaborate descriptions of their post-operative pain, whereas others were less 
forthcoming. Some participants were in pain during the interview, but many reported 
their pain had mostly subsided. The participants’ demeanor during the interview varied; 
some were tearful, some were irritable, and some were in good spirits. While most 
participants were willing to describe their pain experiences, a few questioned why 
discussing their pain was important and expressed some frustration during the 
interviews.  
Pain Management Experiences 
The analysis revealed that the participants’ pain descriptions varied on two major 
dimensions: the degree to which pain was a salient concern in the context of their overall 
recovery during the post-surgical period and the complexity of their pain management 
experiences. 
Salience of pain. The role of pain in the context of the participants’ overall 
recovery experience varied considerably among the participants. For some, pain was not 
a salient concern and, despite the fact that the interviews were focused on pain 
experiences, these participants did not dwell on discussing their pain and often diverted 
the interviews to topics that were of more concern to them, such as the overall course of 
their treatment for their brain tumor or their plans for returning home. Often, these 
participants described their pain as “no big deal,” and indicated it was expected, 
 85 
 
tolerable, or manageable. For other participants, however, pain was an important 
concern in their recovery experience and remained the focus of much of their interviews. 
In some cases, this was because the participants experienced pain that was particularly 
intense. These participants described their pain, at least at one time point, as 
excruciating, debilitating, or unbearable. In other cases, pain was a salient concern 
because it lasted a long period of time, was not well controlled, or interfered with 
recovery activities, such as physical therapy or diagnostic testing. 
  Complexity of pain management experiences. The complexity of participants’ 
pain management experiences also varied considerably. Some participants described 
their pain management experiences as routine, simple, straightforward, and generally 
effective. These patients typically indicated that their level of pain was assessed, they 
received pain medication, and experienced relief. Other participants, however, described 
their pain management experiences as complicated, difficult, or trying. Complex pain 
management experiences could be related to side effects or complications of pain 
medications, pain that could not be well managed, conflictual interactions with 
healthcare providers, or other recovery complications that interfered with pain 
management. 
 To describe the participants’ pain management experiences, therefore, we 
determined that participants might be placed in one of four potential groups (Table 4.2): 
1) pain-as-non-salient, routine pain management; 2) pain-as-non-salient, complex pain 
management; 3) pain-as-salient, routine pain management; and 4) pain-as-salient, 
complex pain management. Based on information extracted from their narratives and the 
descriptions of the two dimensions described above, each participant could readily be 
placed in a group. As would be expected, no participants were placed in the pain-as-
non-salient, complex pain management. Within each of the other three groups, common 
patterns of pain management experiences were identified, and each pattern was given a 
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label that best captured how the participants described that pattern. Table 4.2 presents 
the patterns that comprised the groups. The groups and the patterns are described 
below with verbatim quotations from the participants that reflect each pattern. 
Group 1: Pain-As-Non-Salient, Routine Pain Management 
Twelve participants were placed in Group 1. For participants in this group, pain 
was not a salient concern in the overall context of their recovery and their pain 
management experiences were described as routine. Within this group, four patterns of 
pain management were described. These patterns are labeled as follows: 1) Simply 
getting pain pills; 2) Conferring with staff; 3) Waiting the pain out, and (4) Having no pain 
at all. 
Simply getting pain pills. Four participants described a pain management pattern 
that is best described as simply getting pain pills. These participants had minimal pain 
and described it as discomfort or tenderness. A 77-year-old woman stated that her pain 
“…wasn’t a piercing pain. It was more like a discomfort.” Several were surprised at how 
little pain they had following surgery. This group described their pain management 
experience as simple and straightforward. Either the staff assessed the participants’ pain 
or the participants asked for pain medication, the staff gave them pain medication, and 
the participants experienced relief. The same participant stated, “Well, basically,… they 
[the staff] would ask me, how do you feel? What’s your pain level? And I would tell 
them….And um, they would address that with medication.”   
The participants in this group also used various self-management strategies to 
deal with their pain. These strategies included sleeping, remaining still, placing wet 
washcloths on their foreheads, holding their incisions or surgical sites, and distracting 
themselves with other activities or thoughts. 
Conferring with staff. Five participants described a pain management pattern that 
is best described as conferring with staff. These participants also indicated that their pain 
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was minimal and manageable. A 55-year-old man said, “The pain hasn’t been real 
terrible, not excruciating, so tolerable…I guess.” The participants in this group did not 
just receive pain medication routinely, but rather discussed plans for pain management 
with the staff. In some cases, this involved deciding how much medication to take (e.g. 
“one pill or two”) or deciding when the best time to take the medication would be. For 
example, some participants discussed with staff when to take their pain medication so 
they could participate in therapy or go to sleep. As a result, the participants felt like they 
had some input into how their pain was managed. A 67-year-old woman stated, 
I like the fact that they would let me talk and know if indeed I felt I needed 
something [for pain] or if I thought I could get through, they treated me as 
if I was intelligent. [I would say], ‘Let—let’s wait another hour until the 
meds kick in and then I can maybe sleep through the night.’ Or whatever 
like that. So when they walked you through like that, I appreciated that. 
 
 Some of the participants in this group also listed some self-management 
strategies that they used to deal with their pain. The strategies included dimming the 
lights and drawing the curtains, decreasing stimulation, and limiting visits from family and 
friends. 
Waiting the pain out. Two participants described a pain management pattern that 
is best described as waiting the pain out. These participants also had minimal pain. One 
described it as a “brain freeze” and the other as “very minor.” Both of these participants 
thus just waited for their pain to go away by itself without taking any pain medication to 
manage the discomfort. A 64-year-old woman stated, “You just wait till it goes away. 
[You] just go over the hump and that’s it.”   
These two participants mentioned some self-management strategies as well. 
One mentioned attempting to “leave the surgical site alone,” and the other mentioned 
“working hard” to focus on her breathing. 
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Not having pain at all. One participant, a 67-year-old man, had no pain at all after 
surgery. He simply stated, “[My] head [doesn’t] hurt.” Pain management thus was not a 
concern, and accordingly, he did not need any self-management strategies.  
Group 2: Pain-As-Salient, Routine Pain Management 
Seven participants were placed in Group 2. For participants in this group, pain 
was a salient concern in the overall context of their recovery and their pain management 
experiences were described as routine. Within this group, two patterns of pain 
management were described. These patterns are labeled as follows: 1) Definitely getting 
pain pills; and 2) Staying on top of the pain. 
Definitely getting pain pills. Four participants described a pain management 
pattern that is best described as definitely getting pain pills. These participants had pain 
that was a concern for them because it was severe or enduring, especially soon after 
surgery. They described it as bad, severe, or “hurting a lot.” A 29-year-old man said, 
“The pain [the first day] was extremely excruciating – I can’t say the word. It was 
horrible.” Their pain management pattern was similar to that of simply getting pain pills, 
but because their pain was more problematic, getting medication was a more pressing 
concern. A 66-year-old man said, “I definitely took the pain medication.” These 
participants’ pain management, while more urgent, was nonetheless routine. They 
reported their pain to the staff, the staff gave them pain medications, and typically the 
pain subsided. If it did not, more pain medication was given that then did relieve the 
pain. A 48-year-old woman stated,  
As soon as I woke up, it was like, ‘Oh, my, God, I’m in so much pain.’ And 
they told me how much to rate it. And I said, ‘A 20.’ And she said, ‘Okay.’ 
She said, ‘We’re gonna give you something for it.’ They didn’t let me sit 
there long before they took care of the situation and gave me something 
to take care of it. But yeah, when I first came out of it, it hurt like a mother. 
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Some of these participants also used self-management strategies to manage the 
pain. The strategies included using ice packs, practicing yoga and relaxation, meditating, 
and praying.  
Staying on top of the pain. Three participants described a pain management 
pattern that is best described as staying on top of the pain. These participants 
experienced severe pain, particularly in the first several days after surgery, and felt the 
pain was an obstacle to their recovery. Their pain management experience was marked 
by preemptive efforts not to let the pain take hold. They were vigilant about keeping the 
pain at bay because they recognized that it was harder to manage it once it occurred. In 
some instances, the staff stayed on top of the participants’ pain by assessing it regularly. 
A 23-year-old man stated, “They’d come in three of four times a day [and] would give me 
Norco or Valium or both depending on what I needed…They were pretty on top of 
keeping my pain in check, which was nice.”  In other instances, the participants 
themselves planned ahead so the pain would not take hold. A 29-year-old man 
described severe pain that recurred as soon as his pain medication began to wear off. 
He stated, 
So knowing that [the medication] lasts for four hours, four hours and ten 
or fifteen minutes is important, that way I can let these guys know like I 
did…because I know she’s gonna be busy and that way she can get the 
pills and so forth …because I’m one of four or five people that she’s 
taking care of…so I definitely wanted to let her know that I was ready for 
it. 
 
The participants in this group also used a number of self-management strategies 
to deal with their pain. The strategies included deep breathing, rubbing or squeezing 
their heads, positioning themselves for comfort, and using heat or ice packs to dull the 
pain. Some called upon their faith (e.g., “leaning on Jesus”) and attempted to find 
meaning in their pain. Others held family members’ hands or talked to them to help 
manage the pain.  
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Group 3: Pain-As-Salient, Complex Pain Management 
 
Eight participants were placed in Group 3. For participants in this group, pain was 
a salient concern in the overall context of their recovery and their pain management 
experiences were described as complex. Within this group, two patterns of pain 
management were described. These patterns are labeled as follows: 1) Not staying on 
top of the pain; and 2) Having everything done to help me. 
Not staying on top of the pain. Five participants described a pain management 
pattern that is best described as not staying on top of the pain. Their pain was 
particularly intense. A 56-year-old woman, for example, had excruciating pain following 
surgery. She said, “Oh, yeah, I was crying, shaking, all the nine yards.” In some cases, 
the pain lasted for most of the recovery period. These participants’ experiences were 
marked by a sense that staff were not invested in or able to “stay on top of” their pain. A 
77-year-old man stated, “They were trying to give me Percocet and that takes about an 
hour to kick in, and my pain, they had trouble staying on top of it for a while, so they 
gave me an IV that kicked in right away, and then some Percocet on top of that…” 
In several cases, these participants had difficult pain management experiences 
because a number of factors complicated their pain treatment. These complications 
included severe nausea and constipation due to the pain medication, coughing that 
intensified the pain, adverse reactions to a pain medication, and problems managing 
high blood pressure or blood glucose. A 56-year-old woman who felt that her pain was a 
major factor interfering with her recovery stated, “I even think the blood pressure and all 
that can be very related to the pain and my blood sugar has been up and down. I think a 
lot of it has to do with the pain.” 
As a result, these participants described a somewhat complicated pain 
management regimen that changed frequently. Some were given a combination of 
intravenous pain medications, a variety of oral pain medications, and steroids. The 56-
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year old woman mentioned above stated, “After the morphine it [the pain] got so much 
better…. But they were able to absolutely get me back on the Fentanyl without it 
dropping my oxygen even more, and then they’ve been giving Percocet and Vicodin. So 
that was what kept me pretty much not in pain.” 
The pain management experiences of these participants were also marked with 
some unsatisfying or conflictual interactions with staff. Some participants indicated that 
the staff did not give them the amount of pain medication they desired. These 
participants felt they were given either too many or too few pills. Others felt the staff did 
not give them the pain medication in a timely enough manner to keep the pain at bay. 
The participants’ pain management experiences were in some instances made worse 
because they felt the staff was not listening to them or understanding their experiences. 
A 34-year-old woman, for example, said she would have to repeatedly ask staff for pain 
medication but was told she was getting the strongest medication possible and she 
would “just have to wait” to get more. In some cases, the participants were able to 
negotiate a pain management regimen with staff that they felt was adequate, whereas 
others had more contentious interactions. A 36-year-old woman said she was 
“hardheaded” but did not want to get into “a big argument” with the staff. She explained, 
They [staff] just asked me how much pain I was in. I gave them a number 
and they said, ‘What’s a tolerable – manageable pain for you?’ I said, ‘If 
it’s about a five. I’m good. If it starts to get up to a six, we need to start the 
fentanyl because after six, it starts to go up really quickly from there, so if 
I say it’s six, fentanyl time…’ But at one point, it wasn’t. Because I wasn’t 
getting the fentanyl every hour like I’m supposed to so, it would go back 
to, ‘Okay. We’ve got to get this every hour on the hour again.’ And so it 
got to the point where I’d be like, ‘Give me the fentanyl before you start 
doing your charting because then it will be an hour before you can get 
back in here because I can’t deal with going through this again.’ 
 
Like the other groups, some of these participants attempted to deal with their 
pain through using various self-management strategies. They used heat and ice packs, 
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positioned themselves for comfort, and attempted to distract themselves from the pain 
by talking to others or watching television.  
 Having everything done to help me. Three participants described a pain 
management pattern that is best described as having everything done to help me. These 
participants also experienced intense pain and had other experiences, such as severe 
nausea or a low pulse rate, which complicated their pain management regimen. A 60-
year-old woman, for example, described how her pain management was complicated 
because her pulse went very low and staff had to initially withhold her pain medication, 
resulting in intense pain. The pain management regimens of these participants also 
included a variety of types of pain medication that were changed throughout the 
recovery period due to complications. 
Unlike the other participants with complex pain management patterns, however, 
the participants in this group felt the staff were highly invested in managing the their 
pain, frequently checked on them, and were attentive and understanding. The 
participants had a sense that the staff did “everything in their power” to help manage the 
participants’ pain. A 61-year-old woman stated, 
The nurse was very nice to come in and she said, ‘Well, what can I do for 
you? Just tell me, what do you want me to do because I’ll do anything I 
can.’ And that in itself was nice to hear and she was able to get me a 
medication to calm me down a little bit. 
 
A 54 year-old woman said, “They [the staff] did everything they can to possibly help 
me…. They have been there for me, ‘What can I do to help you?’.” 
 This group used many self-management strategies to address their pain and 
discomfort. These strategies included sleeping, relaxing, lying still, and trying to rest. 
They also relied on the support of family members coming in to visit to take their mind off 
of the pain. One said that crying helped manage the pain and another found eating to be 
helpful.  
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Discussion 
All the participants but one had some pain following their craniotomies. Their 
descriptions of their pain experiences varied on two dimensions: the salience of pain in 
the context of recovery and the complexity of their pain management experiences. 
Based on these two dimensions, we divided the participants into three groups: (1) pain-
as-non-salient, routine pain management, (2) pain-as-salient, routine pain management, 
and (3) pain-as-salient, complex pain management. Many participants, regardless of 
how salient their pain was, described a pain management experience that they 
considered as uneventful or routine. Their pain was managed to their satisfaction and 
involved primarily being given pain medication in a timely manner and experiencing the 
pain medication as effective. Other participants described pain management 
experiences that were more problematic. In some cases, this was because of the 
severity and nature of their pain, complications from surgery, or side effects of the 
medication. In a few cases, this was because of problematic interactions with healthcare 
providers who did not administer medications in a timely manner, listen to the 
participants’ pain-related concerns, or understand their pain experiences.  
Our findings were consistent with those of several other studies that examined 
patients’ experiences with pain management while in the hospital. For example, a study 
by Farooq et al. examined hospitalized post-surgical patients’ satisfaction with acute 
pain management.211 Just as the participants in our study were generally satisfied with 
their interactions with staff regarding pain management, these researchers reported that 
most patients in their study felt their pain was well managed and they were satisfied with 
their experiences with the hospital staff.211 However, consistent with our results, a few of 
the participants in the Farooq et al. study felt that their pain was not well controlled and 
that their pain medications were administered too late.211 Our major finding – that the 
majority of patients had an uneventful course of pain management because they were 
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given analgesics that managed their pain well – was similar to the finding of a study that 
revealed that head and neck cancer patients undergoing radiotherapy felt their pain was 
managed in a timely way.212  
The experiences of the few of our participants who had problematic interactions 
with staff related to pain management was echoed in several other studies of 
hospitalized patients who experienced pain. For example, a study by El-Haddad et al. 
revealed that patients hospitalized with acute low back pain were unable to 
communicate the severity of their pain to staff and felt the staff minimized their pain,213 a 
study Bernhofer et al. revealed that patients hospitalized with irritable bowel disease 
reported that they were judged or discredited by staff for experiencing pain,214 and a 
study by Coleman et al. revealed that patients with sickle cell anemia reported they felt 
misunderstood or not believed when reporting their pain levels.215 While problematic 
interactions with staff were reported in our sample, none of our participants discussed 
feeling stigmatized or doubted about their level of pain. This may suggest that the pain 
management experiences of hospitalized patients with post-surgical pain differ from 
those with acute pain being treated in the context of chronic pain conditions.  
  Finally, just as some of participants employed other “self-help” non-
pharmaceutical strategies to manage their pain, women in a study by Hovind et al. who 
had undergone surgery for breast cancer employed their own pain management 
strategies including physical exercise, relaxation, and distraction.216  
Limitations 
 There are several limitations to this study. First, because our participants were 
hospitalized post-surgical patients who had undergone anesthesia, and most were 
taking pain medications, it is possible that their memories of their experiences with their 
pain and/or how it was managed might have been impaired. Some may have had some 
pain experiences, especially right after surgery, that they could not fully describe, and 
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this might account, in part, for why some described their overall pain experiences as 
non-salient. In addition, the use of a single study site and unit may impact our 
participants’ overall level of satisfaction in part due to that unit’s pain management 
practices. Finally, minorities were underrepresented in our sample. While non-Hispanic 
whites are diagnosed with brain tumors more frequently than other minorities,182 the 
experiences of minority patients were not well represented in our study, and we cannot 
ascertain if they have different pain management experiences.  
Future Research 
In order to further advance our understanding of the pain management 
experiences of patients who have undergone a craniotomy, we suggest conducting 
studies at multiple sites in order to ascertain which pain management experiences might 
be related to the practices of specific units or institutions. Moreover, obtaining a larger 
and more diverse sample would allow for exploration of differences in pain management 
experiences due to demographic factors, such as age or race/ethnicity, and factors 
related to the type of surgery and the type tumor. To understand how pain management 
experiences unfold over time, a multi-method study that combines clinician observations, 
quantitative data such as pain ratings and medication dose, and narratives of patients’ 
subjective experiences throughout the recovery period would be optimal.  
Clinical Implications 
 Despite study limitations, our findings do suggest some clinical implications. 
Clinicians should be aware that while many post-craniotomy patients experience minor 
pain and effective and routine pain management, there are others for whom pain 
management is a trying experience. These patients would benefit from indications that 
staff are attuned to “staying on top” of their pain and receiving information regarding how 
their pain will be managed. Pain management best practices, such as regular 
identification and timely treatment of the side effects and comorbidities that complicate 
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pain management, administration of pain medications in a timely fashion before the pain 
“gets out of control,” continual assessment of the effectiveness of the medication regime, 
and consideration of alternative analgesics when needed, are especially important for 
these patients. Good patient/provider communication, in which patients feel heard and 
understood and have input into decisions made regarding their pain management, is 
foundational to a good pain management experience. Clinicians should also explore with 
patients what self-management strategies would be acceptable to them and which might 
enhance their pain management experiences.  
Conclusion 
 The experiences of patients who have undergone a craniotomy vary according to 
the nature of the pain they experience and their unique experiences of how it is 
managed. Despite some clinician beliefs that post-craniotomy pain is minimal, our 
findings confirm that for some patients it is a salient experience that causes distress and 
interferes with their recovery. Our typology of three distinct types of pain management 
experiences, if further developed and validated, could advance our understanding of the 
diversity of pain experiences following craniotomy and the identification of the unique 
clinical needs of distinct groups of post-craniotomy patients. The study confirms that the 
nature of patient interactions with clinicians clearly influence patients’ pain care 
experiences.  
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Table 4.1. Demographic and Medical Record Data (n=26) 
 n % 
Age  20-29 years 3 11.5 
 30-39 3 11.5 
 40-49 4 15.4 
 50-59 4 15.4 
 60-69 8 30.8 
 70-79 3 11.5 
 80-89 1 3.8 
Gender Female 15 57.7 
Male 11 42.3 
Race Caucasian 25 96.2 
African-American 1 3.8 
Tumor type Glioma/ 
Glioblastoma/ 
Oligodendroglioma/ 
Oligodendroma 
8 30.8 
Meningioma 6 23.1 
Schwannoma 5 19.2 
Carcinoma 3 11.5  
Hemangioblastoma 2 7.7 
Ependyoma 1 3.8 
Hamartoma 1 3.8 
Tumor grade I  11 42.3 
II 2 7.7 
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III 2 7.7 
IV 3 11.5 
Not stated 8 30.8 
Tumor location Frontal 4 15.2 
Frontotemporal 3 11.5 
Temporal  3 11.5 
Posterior fossa  3 11.5 
Skull base  2 7.7 
Suboccipital  2 7.7 
Cerebellar  2 7.7 
Vestibular  1 3.8 
Supratentorial 1 3.8 
Parieto-occipital  1 3.8 
Parietal 1 3.8 
Not stated 3 11.5 
Tumor 
Hemisphere 
Right 15 57.7 
Left 11 42.3 
Surgical 
Approach 
Anterior 
 
25 96.2 
Posterior 1 3.8 
Type of 
craniotomy 
Sedated  
 
17 65.4 
Awake 9 34.6 
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Analgesics 
prescribed1 
Fentanyl  23 88.5 
Hydrocodone-
acetaminophen  
15 57.7 
Acetaminophen 14 53.8 
Oxycodone-
acetaminophen 
9 34.6 
Hydromorphone 6 23.1 
Morphine 5 19.2 
Oxycodone 4 15.4 
Ibuprofen 2 7.7 
Lidoderm 1 3.8 
Acetaminophen-
codeine  
1 3.8 
None 1 3.8 
Steroids 
prescribed 
Dexamethasone 22 84.6 
Hydrocortisone 1 3.8 
None 3 11.5 
Prior pain 
history 
No  24 92.3 
Yes 2 7.7 
Prior opioid 
use 
No 25 96.2 
Yes 1 3.8 
 
 
 
                                                           
1 The total number of analgesics prescribed does not add up to 26 because many patients were 
prescribed more than one medication. 
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Table 4.2. The Four Potential Post-craniotomy Pain Management Groups 
 Routine Pain Management Complex Pain Management 
 
Pain-as-
non-
salient 
Group 1 
Simply getting pain pills 
Conferring with staff 
Waiting the pain out 
Having no pain at all 
 
 
Pain-as-
salient 
Group 2 
Definitely getting pain pills 
Staying on top of the pain 
 
Group 3 
Not staying on top of the pain 
Having everything done to help me 
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CHAPTER FIVE 
Summary of Dissertation Project 
 Post-craniotomy brain tumor patients often experience pain in the post-surgical 
period, and this pain can negatively affect their recovery and surgical outcomes. Most 
research with this population has focused on pharmacological treatments of post-
craniotomy pain and has measured only pain intensity. Little is known, therefore, about 
how these patients experience the quality of their pain and how it is managed while they 
are hospitalized. The overall goal of this dissertation project is to provide an in-depth 
description of the experience of post-craniotomy pain during the post-surgical period. 
The information gained from this project will inform the recognition, treatment, and 
management of pain in the post-craniotomy brain tumor population.   
 This dissertation project is composed of two components. The first component is 
an integrative review of literature examining the evidence of pain and associated 
symptoms in adult, post-craniotomy brain tumor patients. The second component is a 
qualitative descriptive study resulting in two qualitative products. The first product is a 
description of participants’ experiences of the quality of their post-craniotomy pain during 
the post-surgical period, and the second is a description of how they experienced the 
management of their pain during this time.  
Three Dissertation Products 
 Three products are presented in Chapters 2, 3, and 4 of this dissertation. The 
findings of each build upon the previous one. 
  Most studies were randomized, controlled trials conducted outside of the United 
States that tested the effects of pharmacological pain interventions on pain intensity. 
This review revealed that between 60% and 96% of post-craniotomy patients experience 
moderate to severe pain within two days after surgery, and that this pain is associated 
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with nausea, vomiting, changes in blood pressure, and increased length of hospital stay. 
These findings contradict the commonly held belief that craniotomies result in little pain 
and indicate that post-craniotomy pain is a salient experience that affects recovery.  
 Based on the TOUS,217,218 and building upon the findings of the integrative 
review, which reveal that prior research focused only on pain intensity, Product 2 
addresses the quality of post-craniotomy pain as described by participants. The findings 
presented include a description of six types of pain quality: pain as pressure, pain as 
tender or sore, pain as stabbing, pain as throbbing, pain as jarring, and pain as itching. 
The findings illustrate that the quality of post-craniotomy pain varies widely and can be 
described in detail by patients when they are prompted to do so.  
 The findings of Product 3 build upon the first two products by moving beyond the 
focus on pharmacological treatments and pain intensity to describe the management of 
post-craniotomy pain more broadly. These findings reveal that participants’ experiences 
of the management of post-craniotomy pain varied on two major dimensions: the 
salience of pain and the complexity of the pain management experience. Based on 
these two dimensions, four groups of types of pain management experiences were 
identified and labeled as follows: pain-as-non-salient, routine pain management; pain-as-
non-salient, complex pain management; pain-as-salient, routine pain management; and 
pain-as-salient, complex pain management. The findings indicate that pain management 
experiences vary considerably and are influenced by a number of factors, most notably 
the quality of the participants’ interactions with healthcare providers. 
Synthesis of Key Findings 
 Although the findings of the dissertation project are detailed in the three products, 
several overarching themes were apparent when the findings of all three products were 
considered as a whole. These three themes are presented below. 
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Theme 1: Many post-craniotomy patients experience pain in the post-surgical 
period, although their pain experiences vary considerably among patients and 
over time. 
 The majority of participants represented in the integrative review and those who 
participated in the dissertation study experienced pain following their craniotomies. The 
pain experience, however, varied considerably; some participants experienced pain that 
was mild and hardly noticeable, whereas others experienced pain that was severe and 
interfered in important ways with their recovery. Although a few participants in the study 
had considerable lingering pain at the time of the interview, most indicated that their pain 
had lessened gradually over the post-surgical period. Post-craniotomy pain is thus a 
complex and highly individualized experience. 
Theme 2: The quality of the pain that post-craniotomy patients experience is an 
important dimension of the pain experience.  
The quality of pain is an important but not well explored dimension of the post-
craniotomy pain experience. This theme is consistent with the basic tenet of the Theory 
of Unpleasant Symptoms (TOUS)217,218 that suggests that symptoms are multi-
dimensional experiences that are influenced by a wide variety of factors. Just as the 
intensity of pain varies considerably in this population, so to does the quality of pain and 
individuals’ responses to it. Understanding the quality as well as the intensity of post-
craniotomy pain could have important implications for pain management approaches. 
Theme 3: While the management of post-craniotomy pain often focuses on the 
administration of analgesics, pain management is a complex process that is 
influenced by a number of factors. 
Although the participants in the study did indicate that pain medications were the 
primary way their pain was controlled, they also revealed that their pain management 
extended beyond receiving analgesics and was influenced by a number of factors such 
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as nausea and unstable blood pressure, and the quality of interactions with healthcare 
providers. Patient-provider relationships were important in the pain management 
experience suggesting that interactions characterized by good communication may 
improve pain care in this population.  
Strengths of the Dissertation 
 This dissertation project has several strengths and will add to the literature in 
important ways. First, the integrative review of the literature on post-craniotomy pain is 
the first review of its kind to be completed in the past 14 years.219 As such, it contributes 
to our understanding of the state-of-the-science on pain in post-craniotomy patients. 
Second, the qualitative descriptive study was the first to examine the quality of post-
craniotomy pain, thereby adding to a body of literature that has focused almost 
exclusively on pain intensity. Third, while much research has examined the efficacy of 
pharmacological treatment of post-craniotomy pain, this qualitative descriptive study 
focused on several aspects of pain management as patients experienced it in the 
context of the patient-provider relationship. Finally, obtaining patient narratives on post-
craniotomy pain provided a more nuanced description of this experience from patients’ 
perspectives, thus adding their “voices” to our understanding of this type of pain.  
Limitations of the Dissertation 
 The findings of this dissertation study should be understood in the context of 
several limitations. First, the interviews were conducted on a single neurological step-
down unit. Because the unit utilized a standard pain management order set for all 
neurosurgical patients, this common order set might have limited the range of ways in 
which the participants experienced pain. Second, the interviews were conducted at a 
single time point during the first two weeks after surgery. While providing some robust 
descriptions of pain quality and pain management, some participants nevertheless had a 
difficult time remembering and articulating the nature of their pain experiences or how 
 108 
 
these experiences changed over time. Third, participants in the study had undergone 
anesthesia and as a result, it is possible that their memories of the pain experience were 
imprecise. Fourth, minorities were under-represented in our sample. Research suggests 
that different minority groups respond to pain in unique ways,220,221 and because our 
sample included only two minority participants, group differences could not be examined 
in this study. 
Summary of Recommendations for Future Research 
 Several recommendations for future studies are based on study findings as well 
as study limitations. First, conducting studies at multiple sites would allow researchers to 
distinguish pain experiences that are common to post-craniotomy patients and those that 
might be site-specific. Second, interviewing participants at multiple time points could 
result in more detailed descriptions of changes in their pain over the course of the post-
surgical period and allow for triangulation of pain narratives with objective data such a 
pain severity ratings and information about the types, routes, and dose of medication 
administered. Third, a larger and more diverse sample would allow for exploration of 
group differences due to demographic factors such as age and minority group as well as 
factors related to types of surgery and tumor.  
Practice Implications 
 Despite the limitations of this dissertation project, the findings suggest some 
practice implications for pain care for those experiencing post-craniotomy pain. First, 
clinicians should reject the commonly held belief that pain is not an important aspect of 
recovery for the post-craniotomy patient and conduct a comprehensive pain assessment 
that covers all pain dimensions for each patient. We recommend that clinicians, in 
addition to obtaining numerical pain ratings, solicit patients’ narratives of their pain 
experiences by asking how the pain feels and what concerns it raises for them. 
Providing patients with opportunities to discuss their pain experiences could reveal what 
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patients perceive as particularly bothersome, even if it not severe, such as itching pain. 
Second, the findings that pain and its management are experienced in such diverse 
ways indicates that tailored approaches, which may include non-pharmacological 
strategies and self-management techniques, may be needed to improve patient 
outcomes. Third, the findings reinforce that best practices, such as “staying on top” of 
patients’ pain and listening to their concerns, are important. Providers should ensure that 
pain management occurs in the context of high quality patient-provider interactions.  
Conclusion 
 Pain in the post-craniotomy period for brain tumor patients is a salient, complex, 
and varied experience. Patient narratives provide an important vehicle for understanding 
this experience in a comprehensive way. All dimensions of post-craniotomy pain bear 
further investigation using a variety of approaches in order to develop effective, tailored 
interventions to enhance patient outcomes. Pain care provided by attuned and attentive 
providers likely contributes to overall patient satisfaction with post-surgical care.  
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Appendix A 
Inclusion/ Exclusion Criteria 
 
 Inclusion Criteria 
(1) diagnosed with primary brain tumor and surgically treated with craniotomy, 
(2) 21 years of age or older (can provide independent informed consent); and 
(3) able to speak English fluently (to ensure understanding of informed consent and to 
enable full study participation). 
 Exclusion Criteria 
 (1) clinically unstable (including but not limited to presence of post-operative seizures, 
post-operative intracranial hemorrhage, or altered level of consciousness);  
 (2) hearing or speech deficits that would make full study participation impossible;  
 (3) active psychosis; and  
 (4) other cognitive deficits that would interfere with participants’ ability to provide consent 
and participate in an interview.  
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Appendix B 
Preliminary Eligibility Screening 
 
To be obtained from Medical Record: 
1. Diagnosis (ensuring patients hospitalized for primary brain tumor) 
2. Age (ensuring adults aged 21 years of age or older are only study participants, 
enabling independent informed consent) 
3. Length of stay since craniotomy for the treatment of brain tumor (enabling grouping of 
data collected) 
 
4. Evidence of clinical instability (including presence of post-operative seizures, post-
operative intracranial hemorrhage, or altered level of consciousness) 
5. Diagnosis of hearing or speech deficit (to rule out comorbidity that would prevent full 
study participation) 
6. Diagnosis of active psychosis (to rule out comorbidity that would prevent full study 
participation) 
8. Diagnosis of other cognitive deficit (to rule out comorbidities that would prevent full 
study participation) 
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Appendix C 
Confirmation of Eligibility Script 
 
To be obtained from speaking with potential study participant: 
1. My name is Rebecca Guilkey, and I am a doctoral student at Indiana University 
School of Nursing. I am conducting a research study to describe the post-operative 
experience of patients who have had a craniotomy for a brain tumor. Is it all right if I ask 
you a few questions? (verbal consent) 
2. Are you able to speak English fluently?  (ensuring acquisition of informed consent and 
study participation) 
  
3. Do you have difficulty hearing? (ruling out hearing impairment that would preclude 
study participation) 
 
4. Do you have difficulty speaking? (ruling out communicative impairment that would 
preclude study participation) 
 
5. The study I am conducting will include an approximately 30-minute interview here in 
your hospital room where, if you were interested in participating, you would tell me your 
experience of pain on each of the days since you came out of surgery. I am going to use 
the information to help healthcare providers understand how brain tumor patients 
experience pain after craniotomy. Understanding what happens from a patient’s point of 
view will help improve recognition and treatment of pain after surgery. Risks of the study 
are few, but may include discomfort with describing your feelings or the pain you 
experienced. Are you interested in participating in my study? (If potential participant 
states, “Yes,” the investigator will obtain written consent and interviewing will begin. If 
potential participant states, “No,” investigator will thank patient for his or her time and 
leave the room.) 
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Appendix D 
 
INDIANA UNIVERSITY INFORMED CONSENT 
STATEMENT FOR 
 
THE TRAJECTORY OF ADULT POST-CRANIOTOMY PAIN OVER THE POST-OPERATIVE PERIOD 
 
 
 
You are invited to participate in a research study of patients who have had surgery for the 
treatment of a brain tumor. You were selected as a possible subject because you had surgery at 
Methodist Hospital. We ask that you read this form and ask any questions you may have before 
agreeing to be in the study.  
 
The study is being conducted by Diane Von Ah, PhD, RN, FAAN, Indiana University School of 
Nursing, Department of Community and Health Systems and Rebecca E. Guilkey, BA, BSN, RN, 
CCRN, Indiana University School of Nursing, Clinical Nursing Science Doctoral Student. It is 
funded by Sigma Theta Tau International Nursing Honor Society. 
 
STUDY PURPOSE 
 
The purpose of this study is to understand patients’ experiences of pain after brain surgery. This 
study does NOT involve the use of any investigational (not approved by the Food and Drug 
Administration) drugs or devices. 
 
NUMBER OF PEOPLE TAKING PART IN THE STUDY: 
 
If you agree to participate, you will be one of approximately 30 subjects who will be 
participating in this research. 
 
PROCEDURES FOR THE STUDY: 
 
If you agree to be in the study, you will do the following things: 
 
Participate in an interview that should last about 30 minutes. You will be asked to talk about 
your experience of pain on the days after your surgery. These interviews will be audio recorded. 
This interview will be done over the course of 1-2 days, depending on your ability to participate. 
If you agree to be in the study, you will also be agreeing to allow the researcher to look at your 
medical records to understand how your pain was treated after your surgery.  
 
RISKS OF TAKING PART IN THE STUDY: 
 
While on the study, there is a small risk that you may be made uncomfortable by some of the 
questions. There is also a small risk of possible loss of confidentiality. 
 
While completing the interview, you can tell the researcher if you want to skip any question or 
questions with no consequences. You may also tell the researcher if you want to stop the 
interview or continue at another time with no consequences. 
 
If the researcher believes that you are experiencing emotional difficulty that requires the 
assistance of your healthcare professional (doctor, nurse), the researcher will end the interview, 
and with your permission, inform the staff on the unit (doctors, nurses). 
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Your information, including the audio recordings of your interview, will be kept in secure locked 
areas and password-protected files that only the researchers can access. Your identifying 
information (name, contact information) will be removed from the rest of your information and 
kept in a separate, locked file cabinet. 
 
BENEFITS OF TAKING PART IN THE STUDY: 
 
One possible benefit to participation might be satisfaction from being able to participate in a study 
meant to help others with your condition. You will also receive a $25 gift card upon completion of 
your interview, whether you answers all of the questions or not. 
 
ALTERNATIVES TO TAKING PART IN THE STUDY: 
 
Instead of being in the study, you have the option to not participate in the study. 
 
CONFIDENTIALITY 
 
Efforts will be made to keep your personal information confidential. We cannot guarantee 
absolute confidentiality. Your personal information may be disclosed if required by law. Your 
identity will be held in confidence in reports in which the study may be published and in 
databases in which the results may be stored. Audio recordings will only be accessible to the 
researchers and a transcriptionist and will be kept for seven years.  
 
Organizations that may inspect and/or copy your research records for quality assurance and 
data analysis include groups such as the study investigator and his/her research associates, the 
Indiana University Institutional Review Board or its designees, the study sponsor, Sigma Theta 
Tau International Nursing Honor Society, and (as allowed by law) state or federal agencies, 
specifically the Office for Human Research Protections (OHRP) and the Food and Drug 
Administration (FDA), the National Cancer Institute (NCI), etc., who may need to access your 
medical and/or research records. 
 
COSTS 
 
We do not anticipate any costs to you or your insurance company as a result of your 
participation in this study. 
 
PAYMENT 
 
You will receive payment for taking part in this study. Upon completion of the interview, you will 
receive a $25 gift card. 
 
COMPENSATION FOR INJURY 
 
In the event of physical injury resulting from your participation in this research, necessary 
medical treatment will be provided to you and billed as part of your medical expenses. Costs not 
covered by your health care insurer will be your responsibility. Also, it is your responsibility to 
determine the extent of your health care coverage. There is no program in place for other 
monetary compensation for such injuries. However, you are not giving up any legal rights or 
benefits to which you are otherwise entitled. 
 
FINANCIAL INTEREST DISCLOSURE 
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The researchers have no financial interest in this research and will not benefit financially from 
this study. 
 
CONTACTS FOR QUESTIONS OR PROBLEMS 
 
For questions about the study or a research-related injury, contact the researcher Rebecca 
Guilkey. If you cannot reach the researcher during regular business hours (8:00AM-5:00PM), 
please call the IU Human Subjects Office at (317) 278-3458 or (800) 696-2949. After business 
hours, please call your on-call physician. 
 
In the event of an emergency, you may contact Rebecca Guilkey. 
 
For questions about your rights as a research participant or to discuss problems, complaints or 
concerns about a research study, or to obtain information, or offer input, contact the IU Human 
Subjects Office at (317) 278-3458 or (800) 696-2949. 
 
VOLUNTARY NATURE OF STUDY 
 
Taking part in this study is voluntary. You may choose not to take part or may leave the study at 
any time. Leaving the study will not result in any penalty or loss of benefits to which you are 
entitled. Your decision whether or not to participate in this study will not affect your current or 
future relations with Indiana University Health Methodist Hospital, Indiana University, or Indiana 
University School of Nursing. Withdrawing from the study early will not cause a risk to you. 
 
Your participation may be terminated by the investigator without regard to your consent in the 
following circumstances: if you appear to have emotional distress that requires the treatment of a 
healthcare provider. 
 
SUBJECT’S CONSENT 
 
In consideration of all of the above, I give my consent to participate in this research study.  
 
I will be given a copy of this informed consent document to keep for my records. I agree to take 
part in this study. 
 
 
 
Subject’s Printed Name:  
 
Subject’s 
Signature: Date:
  
 (must be dated by the subject) 
 
 
Printed Name of Person Obtaining Consent:  
 
Signature of Person Obtaining Consent: Date
  
 
1
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Appendix E 
Interview Guide 
 
Participants will be interviewed once and asked to discuss their experiences related to 5 different time points: (1) upon waking 
up from surgery; (2) the first post-operative day; (3) the second post-operative day; (4) the third post-operative day; and (5) 
the fourth post-operative day. The interview will proceed according to the following guide: 
 
Post-operative Day 4: 
Thank you for participating in this interview today. I am interested in understanding all I can about your experiences with 
pain, if any, since you have had any since your surgery. I am interested in how you would describe your pain over these 
past four days, how you dealt with it, and how your healthcare providers managed your pain. I am interested in knowing 
whatever you can recall about how you experienced pain. I am going to ask about your pain when you first woke up 
and during each day since you had surgery. 
 Primary 
question 
(Aim 1) 
Follow-up 
questions 
Primary 
question 
(Aim 2) 
Follow-up 
questions 
Primary 
question 
(Aim 3) 
Follow-up 
questions 
Upon 
waking 
up 
What was 
your pain like 
when you 
first woke 
up? 
How would 
you describe 
your pain 
when you first 
woke up? 
Where did you 
experience it? 
How long did it 
last? 
How did you 
endure or 
manage the 
pain when you 
first woke up? 
What 
strategies did 
you use to 
endure or 
manage your 
pain when you 
first woke up? 
How did these 
strategies 
work? 
What else did 
you try? 
Describe any 
interactions 
you had with 
any of your 
healthcare 
providers 
about your 
pain when 
you first woke 
up? 
Who was the 
healthcare provider 
(hcp)? How did the 
interaction begin? 
(e.g., did the 
participant request 
pain relief, was it 
offered by the hcp?) 
What happened 
next? 
(Applicant will ask 
about other 
healthcare providers. 
If they discuss 
interactions with 
physicians, for 
example, ask about 
interactions with 
nurses.) 
 
First 
Post-
What was 
your pain like 
How would 
you describe 
your pain the 
How did you 
endure or 
manage the 
What 
strategies did 
you use to 
Describe any 
interactions 
you had with 
Who was the 
healthcare provider? 
  
 
1
1
9
 
operative 
Day 
the rest of 
that day? 
rest of that 
day? Where 
did you 
experience it? 
How long did it 
last? 
pain the rest 
of that first 
day? 
endure or 
manage your 
pain the rest 
of that first 
day? How did 
these 
strategies 
work? What 
else did you 
try? 
any of your 
healthcare 
providers 
about your 
pain the rest 
of that first 
day. 
How did the 
interaction begin? 
(e.g., did the 
participant request 
pain relief, was it 
offered by the hcp?) 
What happened 
next? 
(Applicant will ask 
about other 
healthcare provider. If 
they discuss 
interactions with 
physicians, for 
example, ask about 
interactions with 
nurses.) 
 
Second  
Post-
operative 
Day 
What was 
your pain like 
the second 
day? 
(Applicant will 
provide 
“anchor” to 
help patient 
differentiate 
post-op days. 
e.g., Your 
second day 
was Tuesday 
– that was 
the first day 
you got out of 
bed.)  
How would 
you describe 
your pain the 
second day? 
Where did you 
experience it?  
How long did it 
last? 
How did you 
endure or 
manage the 
pain the 
second day? 
What 
strategies did 
you use to 
endure or 
manage your 
pain when you 
first got out of 
bed? 
How did these 
strategies 
work? 
What else did 
you try? 
Describe any 
interactions 
you had with 
any of your 
healthcare 
providers 
about your 
pain (here 
provide 
anchor; e.g., 
when you 
first got out of 
bed?) 
Who was the 
healthcare provider? 
How did the 
interaction begin? 
(e.g., did the 
participant request 
pain relief, was it 
offered by the hcp?) 
What happened 
next? 
(Applicant will ask 
about other 
healthcare providers. 
If they discuss 
interactions with 
physicians, for 
example, ask about 
interactions with 
nurses.) 
 
Third 
Post-
What was 
your pain like 
How would 
you describe 
How did you 
endure or 
What 
strategies did 
Describe any 
interactions 
Who was the 
healthcare provider? 
  
 
1
2
0
 
operative 
Day 
the third day? 
(Applicant will 
provide 
“anchor” to 
help patient 
differentiate 
post-op days: 
e.g., Your 
third day was 
Wednesday – 
that was the 
first day you 
were allowed 
to shower.) 
your pain the 
third day? 
Where did you 
experience it?  
How long did it 
last? 
manage the 
pain the third 
day? 
you use to 
endure or 
manage your 
pain when you 
first 
showered? 
How did these 
strategies 
work? 
What else did 
you try? 
you had with 
any of your 
healthcare 
providers 
about your 
pain (here 
provide 
anchor; e.g., 
when you 
first 
showered?) 
How did the 
interaction begin? 
(e.g., did the 
participant request 
pain relief, was it 
offered by the hcp?) 
What happened 
next? 
(Applicant will ask 
about other 
healthcare providers. 
If they discuss 
interactions with 
physicians, for 
example, ask about 
interactions with 
nurses.) 
 
Fourth 
Post-
operative 
Day 
What was 
your pain like 
the fourth 
day? 
(Applicant will 
provide 
“anchor” to 
help patient 
differentiate 
post-op days: 
e.g., Your 
fourth day 
was 
Thursday– 
that was the 
first day you 
were allowed 
to get 
dressed.)  
How would 
you describe 
your pain the 
fourth day? 
Where did you 
experience it?  
How long did it 
last? 
How did you 
endure or 
manage the 
pain the fourth 
day? 
What 
strategies did 
you use to 
endure or 
manage your 
pain when you 
first got 
dressed? 
How did these 
strategies 
work? 
What else did 
you try? 
Describe any 
interactions 
you had with 
any of your 
healthcare 
providers 
about your 
pain (here 
provide 
anchor; e.g., 
when you 
first got 
dressed?) 
Who was the 
healthcare provider? 
How did the 
interaction begin? 
(e.g., did the 
participant request 
pain relief, was it 
offered by the hcp?) 
What happened 
next? 
(Applicant will ask 
about other 
healthcare providers. 
If they discuss 
interactions with 
physicians, for 
example, ask about 
interactions with 
nurses.) 
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Appendix F 
Demographic and Medical Data Sheet 
 
 
Page 1 
Hospital Unit (circle one) 
 
Neurosurgical ICU 
 
 
Neurosurgical Step-Down 
 
Length of Stay (in days) Age BMI 
 
 
 
 
 
 
 
Gender (circle one) 
 
Male 
 
 
Female 
 
Race (circle one) 
 
Caucasian 
 
 
Non-Hispanic White 
 
African-American 
 
 
Asian/ Pacific Islander 
 
Hispanic 
 
 
Native American 
 
Decline to state 
 
 
 
Nicotine Usage (Y or N) Caffeine Usage (Y or N) 
 
 
 
 
Diagnosis ICD-9 Code 
 
 
 
 
Tumor 
Type Grade 
 
 
 
 
Location Hemisphere 
 
 
 
 
 
Proceed to next page  
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Page 2 
Surgery 
Approach Length of Time (minutes) 
 
 
 
Head Positioning Type of Craniotomy (circle one) 
    
Awake 
 
 
Sedated 
 
 
Pain Rating (averaged for each in-patient day) 
Inpatient Day Pain Ratings Average 
Day 0 (day of surgery)   
Day 1   
Day 2   
Day 3   
Day 4   
 
Glasgow Coma Scale Rating (GCS; averaged for each in-patient day) 
Inpatient Day GCS Ratings Average 
Day 0 (day of surgery)   
Day 1   
Day 2   
Day 3   
Day 4   
 
Medications 
Analgesics Prescribed and Dosages Frequency Time Administered 
   
   
   
   
   
   
Steroids Prescribed and Dosages Frequency Time Administered 
    
   
   
   
   
   
 
Prior Pain History (Y or N) Prior Opioid Use (Y or N) 
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Appendix G 
Research Interview Distress Protocol 
 
An adverse event (AE) is defined as any unintended or abnormal reaction or clinical 
condition that is not of benefit to the participant. Either the response/condition was not 
present prior to exposure to the study or participation has worsened the intensity or 
frequency of the response/condition. A reportable adverse event is any unintended or 
abnormal reaction or clinical condition in a subject that (1) places the subject at 
increased risk of harm and (2) was unexpected and (3) was related to the research 
procedures. Extreme fear or anxiety due to study participation may be considered an 
adverse event in a behavioral/cancer control study. Any breach of patient confidentiality 
is considered a reportable adverse event.  
 
Expedited Reporting of Adverse Events 
Regardless of study sponsorship, the DSMC chair and/or coordinator will review all 
expedited SAE reports through OnCore. Expedited reports are completed per IRB 
guidelines and may include the IRB Prompt Reporting form, non-compliance form, 
AdEERS reports, Med Watch, and additional SAE forms as required by the sponsor. 
Submission of this information to the DSMC is additional to any other protocol-specified 
regulatory bodies (e.g., FDA, pharmaceutical company) to be notified. When follow-up 
information is received hard copies or electronic versions of NCI AdEERS forms, Med 
Watch and/or other required forms required by the sponsor should also be provided to 
the DSMC per the current IRB guidelines. The DSMC chair and/or coordinator will 
review expedited SAE reports weekly, and report findings to the DSMC quarterly. 
 
Reporting Death  
Report death per local IRB reporting guidelines. (Section 5.8 of the Unanticipated 
Problems and Noncompliance SOP) 
 
Protocol Deviations  
 Protocol deviations are entered into OnCore and reviewed by the DSMC chair and/or 
coordinator monthly. 
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